- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT00412984
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation (ARISTOTLE)
5. Juni 2018 aktualisiert von: Bristol-Myers Squibb
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
The trial seeks to determine if apixaban, an investigational anticoagulant (blood-thinner) is as effective as standard therapy (warfarin) in preventing stroke and systemic embolism in subjects with atrial fibrillation and risk factors for stroke.
Studienübersicht
Status
Abgeschlossen
Bedingungen
Intervention / Behandlung
Studientyp
Interventionell
Einschreibung (Tatsächlich)
20976
Phase
- Phase 3
Kontakte und Standorte
Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.
Studienorte
-
-
-
Buenos Aires, Argentinien, 1119
- Local Institution
-
Buenos Aires, Argentinien, C1280AEB
- Local Institution
-
Buenos Aires, Argentinien, 1181
- Local Institution
-
Buenos Aires, Argentinien, C1426ANZ
- Local Institution
-
Buenos Aires, Argentinien, 1280
- Local Institution
-
Cordoba, Argentinien, 5000
- Local Institution
-
Cordoba, Argentinien, X5000EPU
- Local Institution
-
Cordoba, Argentinien, X5008KKF
- Local Institution
-
Cordoba, Argentinien, X5003DCE
- Local Institution
-
Salta, Argentinien, 4400
- Local Institution
-
Santa Fe, Argentinien, 3000
- Local Institution
-
Tucuman, Argentinien, T4000NIL
- Local Institution
-
-
Buenos Aires
-
Adrogue, Buenos Aires, Argentinien, 1846
- Local Institution
-
Bahia Blanca, Buenos Aires, Argentinien, B8000FTD
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Argentinien, CP1425A WC
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Argentinien, 1128AAD
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Argentinien, 1128
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Argentinien, 1426 EGR
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Argentinien, C1426 EGR
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Argentinien, CP1425AWC
- Local Institution
-
Ciudad Autonoma De, Buenos Aires, Argentinien, 1180
- Local Institution
-
Ciudad Autonoma De Buenos Aire, Buenos Aires, Argentinien, CI094AAD
- Local Institution
-
Coronel Suarez, Buenos Aires, Argentinien, B7540GHD
- Local Institution
-
Haedo, Buenos Aires, Argentinien, B1706AJU
- Local Institution
-
Junin, Buenos Aires, Argentinien, 6000
- Local Institution
-
La Plata, Buenos Aires, Argentinien, 1900
- Local Institution
-
La Plata, Buenos Aires, Argentinien, B1900AXI
- Local Institution
-
La Plata, Buenos Aires, Argentinien, 1902
- Local Institution
-
Mar Del Plata, Buenos Aires, Argentinien, 7600
- Local Institution
-
Merlo, Buenos Aires, Argentinien, B1722COV
- Local Institution
-
Merlo, Buenos Aires, Argentinien, 1722
- Local Institution
-
Olivos, Buenos Aires, Argentinien, 1602
- Local Institution
-
Quilmes, Buenos Aires, Argentinien, 1878
- Local Institution
-
Ramos Mejia, Buenos Aires, Argentinien, B1704ESN
- Local Institution
-
Ramos Mejia, Buenos Aires, Argentinien, B1704ETD
- Local Institution
-
Ramos Mejia, Buenos Aires, Argentinien, 1706
- Local Institution
-
San Justo, Buenos Aires, Argentinien, 1754
- Local Institution
-
San Martin, Buenos Aires, Argentinien, 1650
- Local Institution
-
San Nicolas, Buenos Aires, Argentinien, 2900
- Local Institution
-
Zarate, Buenos Aires, Argentinien, 2800
- Local Institution
-
Zarate, Buenos Aires, Argentinien, B2800DGH
- Local Institution
-
-
Provincia DE Cordoba
-
Cordoba, Provincia DE Cordoba, Argentinien, 5000
- Local Institution
-
-
RIO Negro
-
Cipolletti, RIO Negro, Argentinien, 8324
- Local Institution
-
-
Santa FE
-
Rosario, Santa FE, Argentinien, 2000
- Local Institution
-
Rosario, Santa FE, Argentinien, S2000CVB
- Local Institution
-
Rosario, Santa FE, Argentinien, S2001ODA
- Local Institution
-
-
Santa Fe
-
Rosario, Santa Fe, Argentinien, S2000CVD
- Local Institution
-
Rosario, Santa Fe, Argentinien, S2000 CVD
- Local Institution
-
-
Tucuman
-
San Miquel De Tucuman, Tucuman, Argentinien, 4000
- Local Institution
-
-
-
-
New South Wales
-
Coffs Harbour, New South Wales, Australien, 2450
- Local Institution
-
Concord, New South Wales, Australien, 2139
- Local Institution
-
Gosford, New South Wales, Australien, 2250
- Local Institution
-
Kogarah, New South Wales, Australien, 2217
- Local Institution
-
Miranda, New South Wales, Australien, 2228
- Local Institution
-
-
Queensland
-
Auchenflower, Queensland, Australien, 4066
- Local Institution
-
Brisbane, Queensland, Australien, 4032
- Local Institution
-
Caboolture, Queensland, Australien, 4510
- Local Institution
-
Herston, Queensland, Australien, 4029
- Local Institution
-
Kippa Ring, Queensland, Australien, 4021
- Local Institution
-
Nambour, Queensland, Australien, 4560
- Local Institution
-
Sherwood, Queensland, Australien, 4075
- Local Institution
-
-
South Australia
-
Adelaide, South Australia, Australien, SA 5000
- Local Institution
-
Ashford, South Australia, Australien, 5035
- Local Institution
-
Bedford Park, South Australia, Australien, 5042
- Local Institution
-
Woodville, South Australia, Australien, 5011
- Local Institution
-
-
Victoria
-
Box Hill, Victoria, Australien, 3128
- Local Institution
-
Dandenong, Victoria, Australien, 3175
- Local Institution
-
Geelong, Victoria, Australien, 3220
- Local Institution
-
-
Western Australia
-
Fremantle, Western Australia, Australien, 6160
- Local Institution
-
Joondalup, Western Australia, Australien, 6027
- Local Institution
-
-
-
-
-
Aalst, Belgien, 9300
- Local Institution
-
Antwerpen, Belgien, 2020
- Local Institution
-
Antwerpen, Belgien, 2060
- Local Institution
-
Arlon, Belgien, 6700
- Local Institution
-
Brugge, Belgien, 8000
- Local Institution
-
Brussels, Belgien, 1090
- Local Institution
-
Dillingen, Belgien, 66763
- Local Institution
-
Genk, Belgien, 3600
- Local Institution
-
Gent, Belgien, 9000
- Local Institution
-
Gilly, Belgien, 6060
- Local Institution
-
Hasselt, Belgien, 3500
- Local Institution
-
Huy, Belgien, 4500
- Local Institution
-
Kortrijk, Belgien, 8500
- Local Institution
-
Menen, Belgien, 8930
- Local Institution
-
Mol, Belgien, 2400
- Local Institution
-
Montegnee, Belgien, 4420
- Local Institution
-
Verviers, Belgien, 4800
- Local Institution
-
Woluwe- Saint Lambert, Belgien, 1200
- Local Institution
-
Yvoir, Belgien, 5530
- Local Institution
-
-
-
-
-
Rio De Janeiro, Brasilien, 20551
- Local Institution
-
Rio De Janeiro, Brasilien, 20551-030
- Local Institution
-
Rio De Janeiro, Brasilien, 22251-030
- Local Institution
-
Rio De Janeiro, Brasilien, 22251
- Local Institution
-
Sao Paulo, Brasilien, 01323-010
- Local Institution
-
Sao Paulo, Brasilien, 01323
- Local Institution
-
Sao Paulo, Brasilien, 04012
- Local Institution
-
Sao Paulo, Brasilien, 04024-002
- Local Institution
-
Sao Paulo, Brasilien, 04038
- Local Institution
-
Sao Paulo, Brasilien, 01221-900
- Local Institution
-
Sao Paulo, Brasilien, 01221
- Local Institution
-
Sao Paulo, Brasilien, 01322-001
- Local Institution
-
Sao Paulo, Brasilien, 01322
- Local Institution
-
Sao Paulo, Brasilien, 01323-001
- Local Institution
-
Sao Paulo, Brasilien, 04012-180
- Local Institution
-
Sao Paulo, Brasilien, 04024
- Local Institution
-
Sao Paulo, Brasilien, 04038-031
- Local Institution
-
Sao Paulo, Brasilien, 08270-070
- Local Institution
-
Sao Paulo, Brasilien, 08270
- Local Institution
-
-
Bahia
-
Salvador, Bahia, Brasilien, 40144
- Local Institution
-
Salvador, Bahia, Brasilien, 41810
- Local Institution
-
Salvador, Bahia, Brasilien, 40144-900
- Local Institution
-
Salvador, Bahia, Brasilien, 41810-010
- Local Institution
-
-
Minas Gerais
-
Belo Horzonte, Minas Gerais, Brasilien, 30150-221
- Local Institution
-
Belo Horzonte, Minas Gerais, Brasilien, 30150
- Local Institution
-
Juiz De Fora, Minas Gerais, Brasilien, 36021-630
- Local Institution
-
Juiz De Fora, Minas Gerais, Brasilien, 36021
- Local Institution
-
Uberaba, Minas Gerais, Brasilien, 38056 055
- Local Institution
-
Uberlandia, Minas Gerais, Brasilien, 38400-299
- Local Institution
-
Uberlandia, Minas Gerais, Brasilien, 38400
- Local Institution
-
-
Para
-
Belem, Para, Brasilien, 66087-660
- Local Institution
-
Belem, Para, Brasilien, 66087
- Local Institution
-
-
Parana
-
Campina Grande Do Sul, Parana, Brasilien, 83430-000
- Local Institution
-
Campina Grande Do Sul, Parana, Brasilien, 83430
- Local Institution
-
Curitiba, Parana, Brasilien, 80010
- Local Institution
-
Curitiba, Parana, Brasilien, 80730
- Local Institution
-
Curitiba, Parana, Brasilien, 80010-030
- Local Institution
-
Curitiba, Parana, Brasilien, 80730-150
- Local Institution
-
Londrina, Parana, Brasilien, 86010-450
- Local Institution
-
Londrina, Parana, Brasilien, 86010
- Local Institution
-
-
RIO Grande DO Norte
-
Natal, RIO Grande DO Norte, Brasilien, 59020-100
- Local Institution
-
-
RIO Grande DO SUL
-
Porte Alegre, RIO Grande DO SUL, Brasilien, 90610-000
- Local Institution
-
Porte Alegre, RIO Grande DO SUL, Brasilien, 90880-480
- Local Institution
-
Porto Alegre, RIO Grande DO SUL, Brasilien, 90035-903
- Local Institution
-
Porto Alegre, RIO Grande DO SUL, Brasilien, 90020-090
- Local Institution
-
Porto Alegre, RIO Grande DO SUL, Brasilien, 90620-001
- Local Institution
-
Porto Alegre, RIO Grande DO SUL, Brasilien, 91350-280
- Local Institution
-
-
Rio Grande Do Norte
-
Natal, Rio Grande Do Norte, Brasilien, 59020
- Local Institution
-
-
Rio Grande Do Sul
-
Porte Alegre, Rio Grande Do Sul, Brasilien, 90610
- Local Institution
-
Porte Alegre, Rio Grande Do Sul, Brasilien, 90880480
- Local Institution
-
Porto Alegre, Rio Grande Do Sul, Brasilien, 90035
- Local Institution
-
Porto Alegre, Rio Grande Do Sul, Brasilien, 90020
- Local Institution
-
Porto Alegre, Rio Grande Do Sul, Brasilien, 90620
- Local Institution
-
Porto Alegre, Rio Grande Do Sul, Brasilien, 91350
- Local Institution
-
-
SAO Paulo
-
Botucatu, SAO Paulo, Brasilien, 18618-000
- Local Institution
-
Campinas, SAO Paulo, Brasilien, 13059-740
- Local Institution
-
Marilia, SAO Paulo, Brasilien, 17515-000
- Local Institution
-
Marilia, SAO Paulo, Brasilien, 17515-460
- Local Institution
-
Marilia, SAO Paulo, Brasilien, 17519-000
- Local Institution
-
San Jose Do Rio Preto, SAO Paulo, Brasilien, 15090-000
- Local Institution
-
Santo Andre, SAO Paulo, Brasilien, 09190-610
- Local Institution
-
Sao Jose Do Rio Preto, SAO Paulo, Brasilien, 15015-750
- Local Institution
-
Sao Jose Do Rio Preto, SAO Paulo, Brasilien, 15015-210
- Local Institution
-
-
Santa Catarina
-
Blumenau, Santa Catarina, Brasilien, 89010
- Local Institution
-
Blumenau, Santa Catarina, Brasilien, 89010-500
- Local Institution
-
Sao Jose, Santa Catarina, Brasilien, 88103
- Local Institution
-
Sao Jose, Santa Catarina, Brasilien, 88103-450
- Local Institution
-
-
Sao Paulo
-
Botucatu, Sao Paulo, Brasilien, 18618
- Local Institution
-
Campinas, Sao Paulo, Brasilien, 13059
- Local Institution
-
Marilia, Sao Paulo, Brasilien, 17519
- Local Institution
-
Marilia, Sao Paulo, Brasilien, 17515
- Local Institution
-
San Jose Do Rio Preto, Sao Paulo, Brasilien, 15090
- Local Institution
-
Santo Andre, Sao Paulo, Brasilien, 09190
- Local Institution
-
Sao Jose Do Rio Preto, Sao Paulo, Brasilien, 15015
- Local Institution
-
-
-
-
LOS Lagos
-
Osorno, LOS Lagos, Chile, 5311089
- Local Institution
-
Osorno, LOS Lagos, Chile, 5311523
- Local Institution
-
-
Metropolitana
-
Santiago, Metropolitana, Chile, 7500520
- Local Institution
-
Santiago, Metropolitana, Chile, 7500922
- Local Institution
-
Santiago, Metropolitana, Chile, 8330074
- Local Institution
-
-
Region DE LA Araucania
-
Temuco, Region DE LA Araucania, Chile, 4781176
- Local Institution
-
-
Region De La Araucania
-
Temuco, Region De La Araucania, Chile, 4781156
- Local Institution
-
-
Valparaiso
-
Temuco, Valparaiso, Chile, 4781173
- Local Institution
-
Vina Del Mar, Valparaiso, Chile, 2570017
- Local Institution
-
-
-
-
Beijing
-
Beijing, Beijing, China, 100050
- Local Institution
-
Beijing, Beijing, China, 100001
- Local Institution
-
Beijing, Beijing, China, 100853
- Local Institution
-
Beijing, Beijing, China, 100020
- Local Institution
-
Beijing, Beijing, China, 100088
- Local Institution
-
Beijing, Beijing, China, 100101
- Local Institution
-
-
Gansu
-
Lanzhou, Gansu, China, 730000
- Local Institution
-
Lanzhou, Gansu, China, 730030
- Local Institution
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510080
- Local Institution
-
Guangzhou, Guangdong, China, 510120
- Local Institution
-
-
Hebei
-
Shijiazhuang, Hebei, China, 050000
- Local Institution
-
-
Heilongjiang
-
Daqing, Heilongjiang, China, 163001
- Local Institution
-
Haerbin, Heilongjiang, China, 150086
- Local Institution
-
Haerbin, Heilongjiang, China, 150001
- Local Institution
-
-
Hubei
-
Wuhan, Hubei, China, 430060
- Local Institution
-
-
Hunan
-
Changsha, Hunan, China, 410000
- Local Institution
-
-
Jiangsu
-
Hangzhou, Jiangsu, China, 310009
- Local Institution
-
Nanjing, Jiangsu, China, 210029
- Local Institution
-
-
Liaoning
-
Dalian, Liaoning, China, 116011
- Local Institution
-
Dalian, Liaoning, China, 116021
- Local Institution
-
Dalian, Liaoning, China, 116027
- Local Institution
-
Shenyang, Liaoning, China, 110016
- Local Institution
-
Shenyang, Liaoning, China, 110003
- Local Institution
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Local Institution
-
Jinan, Shandong, China, 250033
- Local Institution
-
Qingdao, Shandong, China, 266011
- Local Institution
-
-
Shanghai
-
Shanghai, Shanghai, China, 200080
- Local Institution
-
Shanghai, Shanghai, China, 200025
- Local Institution
-
Shanghai, Shanghai, China, 200433
- Local Institution
-
Shanghai, Shanghai, China, 200011
- Local Institution
-
Shanghai, Shanghai, China, 200233
- Local Institution
-
Shanghai, Shanghai, China, 200003
- Local Institution
-
Shanghai, Shanghai, China, 100037
- Local Institution
-
Shanghai, Shanghai, China, 200031
- Local Institution
-
-
Sichuan
-
Chengdu, Sichuan, China, 610041
- Local Institution
-
Chongqing, Sichuan, China, 400010
- Local Institution
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310009
- Local Institution
-
-
-
-
-
Aachen, Deutschland, 52074
- Local Institution
-
Bad Krozingen, Deutschland, 79189
- Local Institution
-
Bad Neustadt/ Salle, Deutschland, 97616
- Local Institution
-
Bad Oeynhausen, Deutschland, 32545
- Local Institution
-
Berlin, Deutschland, 13353
- Local Institution
-
Berlin, Deutschland, 14050
- Local Institution
-
Berlin, Deutschland, 10787
- Local Institution
-
Berlin, Deutschland, 10789
- Local Institution
-
Berlin, Deutschland, 12043
- Local Institution
-
Berlin-Kopenick, Deutschland, 12559
- Local Institution
-
Betzdorf, Deutschland, 57518
- Local Institution
-
Bochum, Deutschland, 44791
- Local Institution
-
Bochum, Deutschland, 44789
- Local Institution
-
Bonn, Deutschland, 53127
- Local Institution
-
Coburg, Deutschland, 96450
- Local Institution
-
Dillingen, Deutschland, 66763
- Local Institution
-
Dresden, Deutschland, 01099
- Local Institution
-
Duisburg, Deutschland, 47139
- Local Institution
-
Essen, Deutschland, 45122
- Local Institution
-
Frankfurt Am Main, Deutschland, 60594
- Local Institution
-
Gottingen, Deutschland, 37075
- Local Institution
-
Halle/Saale, Deutschland, 06120
- Local Institution
-
Hannover, Deutschland, 30625
- Local Institution
-
Heidelberg, Deutschland, 69120
- Local Institution
-
Heidelberg, Deutschland, 69115
- Local Institution
-
Kassel, Deutschland, 34121
- Local Institution
-
Lahr, Deutschland, 77933
- Local Institution
-
Ludwigshafen, Deutschland, 67063
- Local Institution
-
Ludwigshafen, Deutschland, 67073
- Local Institution
-
Mannheim, Deutschland, 68167
- Local Institution
-
Marburg, Deutschland, 35043
- Local Institution
-
Munchen, Deutschland, 81675
- Local Institution
-
Munchen, Deutschland, 80636
- Local Institution
-
Munchen, Deutschland, 81545
- Local Institution
-
Osnabruck, Deutschland, 49076
- Local Institution
-
Regensburg, Deutschland, 93053
- Local Institution
-
Riesa, Deutschland, D-01587
- Local Institution
-
Rostiock, Deutschland, 18057
- Local Institution
-
Trier, Deutschland, 54292
- Local Institution
-
Waren, Deutschland, 17192
- Local Institution
-
Witten, Deutschland, 58455
- Local Institution
-
Wolmirstedt, Deutschland, 39326
- Local Institution
-
Worms, Deutschland, 67550
- Local Institution
-
-
-
-
-
Arhus C, Dänemark, 8000
- Local Institution
-
Esbjerg, Dänemark, 6700
- Local Institution
-
Frederiksberg, Dänemark, 2000
- Local Institution
-
Frederikssund, Dänemark, 3600
- Local Institution
-
Gentofte, Dänemark, 2900
- Local Institution
-
Haderslev, Dänemark, 6100
- Local Institution
-
Hellerup, Dänemark, 2900
- Local Institution
-
Herlev, Dänemark, 2730
- Local Institution
-
Herning, Dänemark, 7400
- Local Institution
-
Hillerod, Dänemark, 3400
- Local Institution
-
Hvidovre, Dänemark, 2650
- Local Institution
-
Kobenhavn, Dänemark, 2100
- Local Institution
-
Kolding, Dänemark, 6000
- Local Institution
-
Odense, Dänemark, 5000
- Local Institution
-
Silkeborg, Dänemark, 8600
- Local Institution
-
Slagelse, Dänemark, 4200
- Local Institution
-
Svendborg, Dänemark, 5700
- Local Institution
-
-
-
-
-
Helsinki, Finnland, 00280
- Local Institution
-
Helsinki, Finnland, FI-00280
- Local Institution
-
Hus, Finnland, 00029
- Local Institution
-
Jyvaskyla, Finnland, 40100
- Local Institution
-
Kemi, Finnland, 94100
- Local Institution
-
Oulu, Finnland, 90100
- Local Institution
-
Pori, Finnland, 28120
- Local Institution
-
Tampere, Finnland, 33100
- Local Institution
-
-
-
-
-
Amiens Cedex 1, Frankreich, 80054
- Local Institution
-
Bordeaux Cedex, Frankreich, 33075
- Local Institution
-
Brest, Frankreich, 29609
- Local Institution
-
Grenoble Cedex 09, Frankreich, 38043
- Local Institution
-
La Seyne Sur Mer, Frankreich, 83500
- Local Institution
-
Paris Cedex 18, Frankreich, 75018
- Local Institution
-
Six Fours Les Plages, Frankreich, 83140
- Local Institution
-
-
-
-
-
Hong Kong, Hongkong
- Local Institution
-
Shatin, Hongkong
- Local Institution
-
-
-
-
-
Ahmedabad, Indien, 380014
- Local Institution
-
Annamalainagar, Indien, 608002
- Local Institution
-
Bangalore, Indien, 560052
- Local Institution
-
Chennai, Indien, 600006
- Local Institution
-
Hyderabad, Indien, 500001
- Local Institution
-
Hyderabad, Indien, 500044
- Local Institution
-
Indore, Indien, 452014
- Local Institution
-
Indore, Indien, 452001
- Local Institution
-
Kolkata, Indien, 700054
- Local Institution
-
Kottayam, Indien, 686016
- Local Institution
-
Lucknow, Indien, 226003
- Local Institution
-
Mumbai Naka, Indien, 422005
- Local Institution
-
Nashik, Indien, 422002
- Local Institution
-
New Delhi, Indien, 110025
- Local Institution
-
New Delhi, Indien, 110060
- Local Institution
-
New Delhi, Indien, 116025
- Local Institution
-
Pune, Indien, 411001
- Local Institution
-
Pune, Indien, 411004
- Local Institution
-
Thrissur, Indien, 680002
- Local Institution
-
Vijayawada, Indien, 520008
- Local Institution
-
-
Andhra Pradesh
-
Visakhapatnam, Andhra Pradesh, Indien, 530003
- Local Institution
-
-
Andhrapradesh
-
Visakhapatnam, Andhrapradesh, Indien, 530002
- Local Institution
-
-
Andra Pradesh
-
Hyderabad, Andra Pradesh, Indien, 500004
- Local Institution
-
-
Gujarat
-
Ahmedabad, Gujarat, Indien, 380060
- Local Institution
-
Vadodara, Gujarat, Indien, 390007
- Local Institution
-
-
Karnataka
-
Bangalore, Karnataka, Indien, 560054
- Local Institution
-
Bangalore, Karnataka, Indien, 5600034
- Local Institution
-
Bangalore, Karnataka, Indien, 560094
- Local Institution
-
Mysore, Karnataka, Indien, 570004
- Local Institution
-
-
Kerela
-
Calicut, Kerela, Indien, 673 004
- Local Institution
-
-
Maharashta
-
Pune, Maharashta, Indien, 411011
- Local Institution
-
-
Maharashtra
-
Nagpur, Maharashtra, Indien, 440010
- Local Institution
-
Nagpur, Maharashtra, Indien, 440012
- Local Institution
-
Pune, Maharashtra, Indien, 411001
- Local Institution
-
Pune, Maharashtra, Indien, 421006
- Local Institution
-
-
Punjab
-
Jalandhar, Punjab, Indien, 144008
- Local Institution
-
-
Rajasthan
-
Bikaner, Rajasthan, Indien, 334001
- Local Institution
-
Bikaner, Rajasthan, Indien, 334003
- Local Institution
-
-
Uttar Pradesh
-
Lucknow, Uttar Pradesh, Indien, 226003
- Local Institution
-
-
-
-
-
Afula, Israel, 18101
- Local Institution
-
Ashkelon, Israel, 78306
- Local Institution
-
Givatayim, Israel, 53583
- Local Institution
-
Hadera, Israel, 38100
- Local Institution
-
Haifa, Israel, 31096
- Local Institution
-
Haifa, Israel, 34362
- Local Institution
-
Holon, Israel, 58100
- Local Institution
-
Jerusalem, Israel, 91120
- Local Institution
-
Jerusalem, Israel, 91240
- Local Institution
-
Kfar-Saba, Israel, 44281
- Local Institution
-
Nazareth, Israel, 16100
- Local Institution
-
Nazareth, Israel, 16000
- Local Institution
-
Petach-Tikva, Israel, 49100
- Local Institution
-
Safed, Israel, 13100
- Local Institution
-
Tel Aviv, Israel, 64239
- Local Institution
-
-
-
-
-
Ascoli Piceno, Italien, 63100
- Local Institution
-
Campobasso, Italien, 86100
- Local Institution
-
Chieti, Italien, 66013
- Local Institution
-
Cremona, Italien, 26100
- Local Institution
-
Fidenza (Pr), Italien, 43036
- Local Institution
-
Genova, Italien, 16132
- Local Institution
-
Isernia, Italien, 86170
- Local Institution
-
Livorno, Italien, 57100
- Local Institution
-
Milano, Italien, 20132
- Local Institution
-
Napoli, Italien, 80131
- Local Institution
-
Palermo, Italien, 90127
- Local Institution
-
Reggio Emilia, Italien, 42100
- Local Institution
-
Roma, Italien, 00168
- Local Institution
-
San Daniele De Friuli, Italien, 33038
- Local Institution
-
Torino, Italien, 10153
- Local Institution
-
Vittorio Veneto (Tv), Italien, 31029
- Local Institution
-
-
Lucca
-
Lido Di Camaiore, Lucca, Italien, 55043
- Local Institution
-
-
-
-
-
Fukui, Japan, 9100067
- Local Institution
-
Kagoshima, Japan, 8920822
- Local Institution
-
Kyoto, Japan, 6168152
- Local Institution
-
Nagasaki, Japan, 852-8102
- Local Institution
-
Oita, Japan, 8700033
- Local Institution
-
Osaka, Japan, 558-8558
- Local Institution
-
Osaka, Japan, 551-0032
- Local Institution
-
Osaka, Japan, 5510032
- Local Institution
-
Saga, Japan, 8490917
- Local Institution
-
-
Fukuoka
-
Itoshima City, Fukuoka, Japan, 819-1104
- Local Institution
-
Kurume, Fukuoka, Japan, 8390863
- Local Institution
-
Ohkawa-City, Fukuoka, Japan, 8310016
- Local Institution
-
-
Fukushima
-
Shirakawa City, Fukushima, Japan, 961-0005
- Local Institution
-
-
Gunma
-
Takasaki City, Gunma, Japan, 3700829
- Local Institution
-
-
Hokkaido
-
Asahikawa-Shi, Hokkaido, Japan, 0788214
- Local Institution
-
Katou-Gun, Hokkaido, Japan, 0800111
- Local Institution
-
Katou-gun, Hokkaido, Japan, 080111
- Local Institution
-
Sapporo-Shi, Hokkaido, Japan, 0028043
- Local Institution
-
Tomakomai-Shi, Hokkaido, Japan, 002-8043
- Local Institution
-
Tomakomai-shi, Hokkaido, Japan, 0028043
- Local Institution
-
Yubari, Hokkaido, Japan, 0680402
- Local Institution
-
-
Hyogo
-
Kobe, Hyogo, Japan, 6540026
- Local Institution
-
-
Kagoshima Prefecture
-
Izumi City, Kagoshima Prefecture, Japan, 8990131
- Local Institution
-
-
Kanagawa
-
Isehara, Kanagawa, Japan, 2591193
- Local Institution
-
Yokohama, Kanagawa, Japan, 2458575
- Local Institution
-
Yokohama City, Kanagawa, Japan, 2278501
- Local Institution
-
Yokosuka, Kanagawa, Japan, 2388567
- Local Institution
-
-
Miyagi
-
Sendai City, Miyagi, Japan, 983-8520
- Local Institution
-
-
Nara
-
Nara City, Nara, Japan, 630-8305
- Local Institution
-
-
Osaka
-
Izumi City, Osaka, Japan, 594-0071
- Local Institution
-
Osaka City, Osaka, Japan, 5330022
- Local Institution
-
Osaka-Shi, Osaka, Japan, 540-0006
- Local Institution
-
Osaka-shi, Osaka, Japan, 5400006
- Local Institution
-
Suita-City, Osaka, Japan, 5658565
- Local Institution
-
Takatsuki City, Osaka, Japan, 5690852
- Local Institution
-
Yao, Osaka, Japan, 5810036
- Local Institution
-
-
Saga
-
Saga City, Saga, Japan, 840-8571
- Local Institution
-
Saga City, Saga, Japan, 849-8501
- Local Institution
-
-
Saitama
-
Kasukabe-Shi, Saitama, Japan, 344-0035
- Local Institution
-
Kasukabe-shi, Saitama, Japan, 3440035
- Local Institution
-
-
Tokyo
-
Itabashi-Ku, Tokyo, Japan, 173-0015
- Local Institution
-
Itabashi-ku, Tokyo, Japan, 1730015
- Local Institution
-
Meguro-Ku, Tokyo, Japan, 153-8515
- Local Institution
-
Meguro-ku, Tokyo, Japan, 1538515
- Local Institution
-
Shinagawa-Ku, Tokyo, Japan, 1428666
- Local Institution
-
-
Toyama
-
Toyama City, Toyama, Japan, 9308550
- Local Institution
-
-
Yamaguchi
-
Iwakuni, Yamaguchi, Japan, 7400021
- Local Institution
-
-
-
-
-
Quebec, Kanada, G1J 1Z6
- Local Institution
-
-
Alberta
-
Calgary, Alberta, Kanada, T2E 7C5
- Local Institution
-
Edmonton, Alberta, Kanada, T6G 2B7
- Local Institution
-
Edmonton, Alberta, Kanada, T5X 3N5
- Local Institution
-
Edmonton, Alberta, Kanada, TSA 4L8
- Local Institution
-
Edmonton, Alberta, Kanada, T56-3NJ
- Local Institution
-
-
British Columbia
-
Burnaby, British Columbia, Kanada, V5G 1T4
- Local Institution
-
Nanaimo, British Columbia, Kanada, V9R 3G9
- Local Institution
-
New Westminster, British Columbia, Kanada, V3L 3W4
- Local Institution
-
North Vancouver, British Columbia, Kanada, V7N 4M2
- Local Institution
-
Victoria, British Columbia, Kanada, V8R 4R2
- Local Institution
-
-
Manitoba
-
Winnipeg, Manitoba, Kanada, R2V 4W3
- Local Institution
-
-
New Brunswick
-
Bathurst, New Brunswick, Kanada, E2A 4X7
- Local Institution
-
-
Newfoundland and Labrador
-
Mount Pearl, Newfoundland and Labrador, Kanada, A1N 1W7
- Local Institution
-
St Johns, Newfoundland and Labrador, Kanada, A1B 3V6
- Local Institution
-
St. John'S, Newfoundland and Labrador, Kanada, A1A 3R5
- Local Institution
-
St. John'S, Newfoundland and Labrador, Kanada, A1E 2C2
- Local Institution
-
-
Ontario
-
Brampton, Ontario, Kanada, L6Z 4N5
- Local Institution
-
Burlington, Ontario, Kanada, L7M 4Y1
- Local Institution
-
Cambridge, Ontario, Kanada, N1R 7R1
- Local Institution
-
Cambridge, Ontario, Kanada, N1R 6V6
- Local Institution
-
Hamilton, Ontario, Kanada, L8L 2X2
- Local Institution
-
London, Ontario, Kanada, N6G 2V2
- Local Institution
-
Mississauga, Ontario, Kanada, L5B 4A2
- Local Institution
-
Newmarket, Ontario, Kanada, L3Y 5G8
- Local Institution
-
Newmarket, Ontario, Kanada, L3Y 8C3
- Local Institution
-
Niagara Falls, Ontario, Kanada, L2E 7H1
- Local Institution
-
Niagara Falls, Ontario, Kanada, L2E7H1
- Local Institution
-
North Bay, Ontario, Kanada, P1B 2H3
- Local Institution
-
Oshawa, Ontario, Kanada, L1J 2J9
- Local Institution
-
Oshawa, Ontario, Kanada, L1J 2K1
- Local Institution
-
Ottawa, Ontario, Kanada, K1Y 4E9
- Local Institution
-
Ottawa, Ontario, Kanada, K1Y 4W7
- Local Institution
-
Sarnia, Ontario, Kanada, N7T 4X3
- Local Institution
-
Scarborough, Ontario, Kanada, M1B 5N1
- Local Institution
-
Sudbury, Ontario, Kanada, P3E 3B8
- Local Institution
-
Sudbury, Ontario, Kanada, P3C 5K7
- Local Institution
-
Sudbury, Ontario, Kanada, P3E 2N8
- Local Institution
-
Sudbury, Ontario, Kanada, P3C5K7
- Local Institution
-
Toronto, Ontario, Kanada, M9W 4L6
- Local Institution
-
Toronto, Ontario, Kanada, M5B 1W8
- Local Institution
-
Weston, Ontario, Kanada, M9N 1W4
- Local Institution
-
-
Prince Edward Island
-
Charlottetown, Prince Edward Island, Kanada, C1A 5Y9
- Local Institution
-
-
Quebec
-
Drummondville, Quebec, Kanada, J2B 7T1
- Local Institution
-
Greenfield Park, Quebec, Kanada, J4V 2G8
- Local Institution
-
Lachine, Quebec, Kanada, H8S 2E4
- Local Institution
-
Levis, Quebec, Kanada, G6V 4Z5
- Local Institution
-
Longueuil, Quebec, Kanada, J4K 1C8
- Local Institution
-
Longueuil, Quebec, Kanada, J4N 0C9
- Local Institution
-
Longueuil, Quebec, Kanada, J4N 1C2
- Local Institution
-
Montreal, Quebec, Kanada, H3T 1E2
- Local Institution
-
Montreal, Quebec, Kanada, H3A 1A1
- Local Institution
-
Montreal, Quebec, Kanada, H1T 1C8
- Local Institution
-
Montreal, Quebec, Kanada, H2W 1T8
- Local Institution
-
Montreal, Quebec, Kanada, W3R-153
- Local Institution
-
Pointe- Claire, Quebec, Kanada, H9R 3J1
- Local Institution
-
St-Lambert, Quebec, Kanada, J4P 2H4
- Local Institution
-
Ste-Foy, Quebec, Kanada, G1W 4R4
- Local Institution
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Kanada, S7L OY7
- Local Institution
-
-
-
-
-
Barranquilla, Kolumbien
- Local Institution
-
Barranquilla, Kolumbien, XXXXX
- Local Institution
-
Bogota, Kolumbien
- Local Institution
-
Bogota, Kolumbien, 000
- Local Institution
-
Cali, Kolumbien
- Local Institution
-
Medellin, Kolumbien
- Local Institution
-
-
Antioquia
-
Medellin, Antioquia, Kolumbien
- Local Institution
-
-
-
-
-
Busan, Korea, Republik von, 602-702
- Local Institution
-
Daegu, Korea, Republik von, 700-712
- Local Institution
-
Daegu, Korea, Republik von, 705-717
- Local Institution
-
Daejon, Korea, Republik von, 302-718
- Local Institution
-
Goyang, Korea, Republik von, 411-706
- Local Institution
-
Gwang Ju, Korea, Republik von, 501-757
- Local Institution
-
Gyeonggi, Korea, Republik von, 463-707
- Local Institution
-
Pusan, Korea, Republik von, 602-739
- Local Institution
-
Scongnam-Si, Korea, Republik von, 463-712
- Local Institution
-
Seoul, Korea, Republik von, 110-744
- Local Institution
-
Seoul, Korea, Republik von, 143-729
- Local Institution
-
Seoul, Korea, Republik von, 130-709
- Local Institution
-
Suwon, Korea, Republik von, 443-721
- Local Institution
-
-
Gyeonggi-Do
-
Anyang-Si, Gyeonggi-Do, Korea, Republik von, 431-070
- Local Institution
-
-
Korea
-
Incheon, Korea, Korea, Republik von, 400-711
- Local Institution
-
-
-
-
-
Kuala Lumpur, Malaysia, 56000
- Local Institution
-
Kuala Lumpur, Malaysia, 59100
- Local Institution
-
-
Kelantan
-
Kubang Kerian, Kelantan, Malaysia, 16150
- Local Institution
-
-
Sarawak
-
Kota Samarahan, Sarawak, Malaysia, 94300
- Local Institution
-
-
Selangor
-
Batu Caves, Selangor, Malaysia, 68100
- Local Institution
-
-
-
-
-
Puebla, Mexiko, 11490
- Local Institution
-
Queretaro, Mexiko, 76000
- Local Institution
-
-
BAJA California
-
Tijuana, BAJA California, Mexiko, 22500
- Local Institution
-
-
Distrito Federal
-
Col. Toriello Guerra, Distrito Federal, Mexiko, CP 14050
- Local Institution
-
Mexico City, Distrito Federal, Mexiko, 06726
- Local Institution
-
Mexico City, Distrito Federal, Mexiko, 14080
- Local Institution
-
Mexico City, Distrito Federal, Mexiko, 07760
- Local Institution
-
Mexico City, Distrito Federal, Mexiko, 06070
- Local Institution
-
Mexico City, Distrito Federal, Mexiko, 10700
- Local Institution
-
-
Jalisco
-
Guadalajara, Jalisco, Mexiko, 44200
- Local Institution
-
Guadalajara, Jalisco, Mexiko, 44600
- Local Institution
-
Guadalajara, Jalisco, Mexiko, 44656
- Local Institution
-
-
Michoacan
-
Morelia, Michoacan, Mexiko, 58000
- Local Institution
-
-
Nuevo LEON
-
Monterrey, Nuevo LEON, Mexiko, 64710
- Local Institution
-
Monterrey, Nuevo LEON, Mexiko, 64000
- Local Institution
-
Monterrey, Nuevo LEON, Mexiko, 64700
- Local Institution
-
-
Sinaloa
-
Culiacan, Sinaloa, Mexiko, 80020
- Local Institution
-
-
Veracruz
-
Jalapa, Veracruz, Mexiko, 91020
- Local Institution
-
-
-
-
-
Breda, Niederlande, 4818 CK
- Local Institution
-
Deventer, Niederlande, 7416 SE
- Local Institution
-
Eindhoven, Niederlande, 5623 EJ
- Local Institution
-
Eindhoven, Niederlande, 5623EJ
- Local Institution
-
Enschede, Niederlande, 7513 ER
- Local Institution
-
Hardenberg, Niederlande, 7772 SE
- Local Institution
-
Hilversum, Niederlande, 1213 XZ
- Local Institution
-
Nijmegen, Niederlande, 6525 GA
- Local Institution
-
Oss, Niederlande, 5342 BT
- Local Institution
-
Rotterdam, Niederlande, 3045 PM
- Local Institution
-
S-Hertogenbosch, Niederlande, 5211 NL
- Local Institution
-
Tiel, Niederlande, 4002 WP
- Local Institution
-
Utrecht, Niederlande, 3582 KE
- Local Institution
-
Velp, Niederlande, 6883 AZ
- Local Institution
-
-
-
-
-
Alesund, Norwegen, 6003
- Local Institution
-
Bergen, Norwegen, 5021
- Local Institution
-
Bergen, Norwegen, N-5021
- Local Institution
-
Elverum, Norwegen, 2408
- Local Institution
-
Flekkefjord, Norwegen, 4400
- Local Institution
-
Nesttun, Norwegen, 5221
- Local Institution
-
Oslo, Norwegen, 0407
- Local Institution
-
Skien, Norwegen, 3710
- Local Institution
-
Stavanger, Norwegen, 4064
- Local Institution
-
Straume, Norwegen, 5353
- Local Institution
-
Tonsberg, Norwegen, 3116
- Local Institution
-
Tromso, Norwegen, 9038
- Local Institution
-
-
-
-
-
Lima, Peru, LIMA 33
- Local Institution
-
Lima, Peru, LIMA 01
- Local Institution
-
Lima, Peru, LIMA 1
- Local Institution
-
-
Callao
-
Bellavista, Callao, Peru, 2176
- Local Institution
-
Bellavista, Callao, Peru, CALLAO 2
- Local Institution
-
-
Lambayeque
-
Chiclayo, Lambayeque, Peru, CIX
- Local Institution
-
-
Lima
-
Jesus Maria, Lima, Peru, 11
- Local Institution
-
Jesus Maria, Lima, Peru, LIMA 11
- Local Institution
-
Miraflores, Lima, Peru, LIMA 18
- Local Institution
-
San Borja, Lima, Peru, LIMA 41
- Local Institution
-
San Martin De Porres, Lima, Peru, LIMA 31
- Local Institution
-
-
-
-
-
Manila, Philippinen, 1000
- Local Institution
-
Manila, Philippinen, 1008
- Local Institution
-
Naga City, Philippinen, 4400
- Local Institution
-
Pasig City, Philippinen, 1600
- Local Institution
-
Quezon, Philippinen, 1100
- Local Institution
-
Quezon City, Philippinen, 1102
- Local Institution
-
San Juan, Philippinen, 1100
- Local Institution
-
-
Ilocos Norte
-
Laoag City, Ilocos Norte, Philippinen, 2900
- Local Institution
-
-
-
-
-
Gdynia, Polen, 81-423
- Local Institution
-
Gdynia, Polen, 81-472
- Local Institution
-
Gdynia, Polen, 81-519
- Local Institution
-
Grodzisk Mazowiecki, Polen, 05-825
- Local Institution
-
Inowroclaw, Polen, 88-100
- Local Institution
-
Kielce, Polen, 25-736
- Local Institution
-
Kielce, Polen, 25-763
- Local Institution
-
Krakow, Polen, 31-202
- Local Institution
-
Krakow, Polen, 30-092
- Local Institution
-
Krakow, Polen, 31-135
- Local Institution
-
Lodz, Polen, 91-347
- Local Institution
-
Lodz, Polen, 91347
- Local Institution
-
Piotrkow Trybunalski, Polen, 97-300
- Local Institution
-
Plock, Polen, 09-402
- Local Institution
-
Plock, Polen, 09-400
- Local Institution
-
Plonsk, Polen, 09-100
- Local Institution
-
Poznan, Polen, 60-531
- Local Institution
-
Poznan, Polen, 60479
- Local Institution
-
Ruda Slaska, Polen, 41-703
- Local Institution
-
Skierniewice, Polen, 96-100
- Local Institution
-
Slupsk, Polen, 76-200
- Local Institution
-
Torun, Polen, 87100
- Local Institution
-
Warszawa, Polen, 01-138
- Local Institution
-
Warszawa, Polen, 04-073
- Local Institution
-
Warszawa, Polen, 04-628
- Local Institution
-
Warszawa, Polen, 04-749
- Local Institution
-
Wegrow, Polen, 07100
- Local Institution
-
-
-
-
-
Cayey, Puerto Rico, 00736
- Local Institution
-
Cidra, Puerto Rico, 00739
- Local Institution
-
Ponce, Puerto Rico, 00717
- Local Institution
-
-
-
-
-
Baia Mare, Rumänien, 430031
- Local Institution
-
Bucharest, Rumänien, 011192
- Local Institution
-
Bucharest, Rumänien, 020125
- Local Institution
-
Bucharest, Rumänien, 050098
- Local Institution
-
Bucharest, Rumänien, 021659
- Local Institution
-
Bucharest, Rumänien, 030572
- Local Institution
-
Cluj Napoca, Rumänien, 400001
- Local Institution
-
Cluj Napoca, Rumänien, 400347
- Local Institution
-
Iasi, Rumänien, 700503
- Local Institution
-
Oradea, Rumänien, 410169
- Local Institution
-
Sibiu, Rumänien, 550245
- Local Institution
-
Targu-Mures, Rumänien, 540103
- Local Institution
-
Timisoara, Rumänien, 300024
- Local Institution
-
Timisoara, Rumänien, 300320
- Local Institution
-
Tirgu Mures, Rumänien, 540136
- Local Institution
-
-
-
-
-
Chelyabinsk, Russische Föderation, 454136
- Local Institution
-
Chita, Russische Föderation, 672090
- Local Institution
-
Dzerzhinskiy, Russische Föderation, 140091
- Local Institution
-
Kazan, Russische Föderation, 420012
- Local Institution
-
Kemerovo, Russische Föderation, 650002
- Local Institution
-
Kirovsk, Russische Föderation, 187342
- Local Institution
-
Krasnodar, Russische Föderation, 350042
- Local Institution
-
Moscow, Russische Föderation, 119992
- Local Institution
-
Moscow, Russische Föderation, 125367
- Local Institution
-
Moscow, Russische Föderation, 109240
- Local Institution
-
Moscow, Russische Föderation, 105229
- Local Institution
-
Moscow, Russische Föderation, 111539
- Local Institution
-
Moscow, Russische Föderation, 115487
- Local Institution
-
Moscow, Russische Föderation, 115093
- Local Institution
-
Moscow, Russische Föderation, 121552
- Local Institution
-
Moscow, Russische Föderation, 117593
- Local Institution
-
Moscow, Russische Föderation, 127018
- Local Institution
-
Moscow, Russische Föderation, 125284
- Local Institution
-
Moscow, Russische Föderation, 111020
- Local Institution
-
Moscow, Russische Föderation, 119121
- Local Institution
-
Moscow, Russische Föderation, 121356
- Local Institution
-
Moscow, Russische Föderation, 117556
- Local Institution
-
Moscow, Russische Föderation, 119048
- Local Institution
-
Moscow, Russische Föderation, 123182
- Local Institution
-
Moscow, Russische Föderation, 125206
- Local Institution
-
Moscow, Russische Föderation, 125424
- Local Institution
-
Moscow, Russische Föderation, 129090
- Local Institution
-
Nizhni Novgorod, Russische Föderation, 603003
- Local Institution
-
Nizhni Novgorod, Russische Föderation, 603005
- Local Institution
-
Novosibirsk, Russische Föderation, 630008
- Local Institution
-
Novosibirsk, Russische Föderation, 630054
- Local Institution
-
Odintsovo, Russische Föderation, 143000
- Local Institution
-
Penza, Russische Föderation, 440026
- Local Institution
-
Perm, Russische Föderation, 614097
- Local Institution
-
Rostov-On-Don, Russische Föderation, 344022
- Local Institution
-
Ryazan, Russische Föderation, 390026
- Local Institution
-
Saint Petersburg, Russische Föderation, 193312
- Local Institution
-
Saint Petersburg, Russische Föderation, 193144
- Local Institution
-
Saint-Petersburg, Russische Föderation, 190103
- Local Institution
-
Saint-Petersburg, Russische Föderation, 191025
- Local Institution
-
Saint-Petersburg, Russische Föderation, 193163
- Local Institution
-
Saint-Petersburg, Russische Föderation, 196601
- Local Institution
-
Saint-Petersburg, Russische Föderation, 198013
- Local Institution
-
Samara, Russische Föderation, 443070
- Local Institution
-
Saratov, Russische Föderation, 410002
- Local Institution
-
St Petersburg, Russische Föderation, 198013
- Local Institution
-
St Petersburg, Russische Föderation, 192288
- Local Institution
-
St-Petersburg, Russische Föderation, 194354
- Local Institution
-
St-Petersburg, Russische Föderation, 195271
- Local Institution
-
St. Petersburg, Russische Föderation, 197341
- Local Institution
-
St. Petersburg, Russische Föderation, 197110
- Local Institution
-
St.-Petersburg, Russische Föderation, 197341
- Local Institution
-
St.Petersburg, Russische Föderation, 199106
- Local Institution
-
Tomsk, Russische Föderation, 634012
- Local Institution
-
Tumen, Russische Föderation, 625023
- Local Institution
-
Tver, Russische Föderation, 170036
- Local Institution
-
Voronezh, Russische Föderation, 394066
- Local Institution
-
Voronezh, Russische Föderation, 394065
- Local Institution
-
Yaroslavl, Russische Föderation, 150030
- Local Institution
-
Yaroslavl, Russische Föderation, 150003
- Local Institution
-
Yaroslavl, Russische Föderation, 150002
- Local Institution
-
Zheleznodorozhniy, Russische Föderation, 143920
- Local Institution
-
Zhukovsky, Russische Föderation, 140160
- Local Institution
-
Zhukovsky, Russische Föderation, 140180
- Local Institution
-
-
-
-
-
Goteberg, Schweden, 413 45
- Local Institution
-
Helsingborg, Schweden, 251 87
- Local Institution
-
Linkoping, Schweden, 581 85
- Local Institution
-
Lund, Schweden, 222 21
- Local Institution
-
Orebro, Schweden, 70185
- Local Institution
-
Orebro, Schweden, 701 85
- Local Institution
-
Skelleftea, Schweden, 931 86
- Local Institution
-
Stockholm, Schweden, 141 86
- Local Institution
-
Stockholm, Schweden, 171 76
- Local Institution
-
Stockholm, Schweden, 111 57
- Local Institution
-
Stockholm, Schweden, 118 83
- Local Institution
-
Stockholm, Schweden, 111 35
- Local Institution
-
Uppsala, Schweden, 751 85
- Local Institution
-
Vaxjo, Schweden, 351 85
- Local Institution
-
-
-
-
-
Baden, Schweiz, 5404
- Local Institution
-
Bern, Schweiz, 3010
- Local Institution
-
-
-
-
-
Singapore, Singapur, 168752
- Local Institution
-
-
-
-
-
Albacete, Spanien, 02006
- Local Institution
-
Barcelona, Spanien, 08035
- Local Institution
-
Barcelona, Spanien, 08003
- Local Institution
-
Elda, Spanien, 03600
- Local Institution
-
Figueres, Spanien, 17600
- Local Institution
-
Gerona, Spanien, 17007
- Local Institution
-
Las Palmas, Spanien, 35010
- Local Institution
-
Madrid, Spanien, 28006
- Local Institution
-
Madrid, Spanien, 28046
- Local Institution
-
Madrid, Spanien, 28040
- Local Institution
-
Palma De Mallorca, Spanien, 07010
- Local Institution
-
San Sebastian De Los Reyes, Spanien, 28703
- Local Institution
-
Tarragona, Spanien, 43007
- Local Institution
-
Viladecans, Spanien, 08840
- Local Institution
-
-
Alicante
-
San Juan, Alicante, Spanien, 03550
- Local Institution
-
Torrevieja, Alicante, Spanien, 03186
- Local Institution
-
-
Almeria
-
La Canada, Almeria, Spanien, 04120
- Local Institution
-
-
Galicia
-
Lugo, Galicia, Spanien, 27003
- Local Institution
-
-
-
-
Bloemfontein
-
Westdene, Bloemfontein, Südafrika, 9301
- Local Institution
-
-
Cape Town
-
Observatory, Cape Town, Südafrika, 7925
- Local Institution
-
-
Gauteng
-
Pretoria, Gauteng, Südafrika, 0084
- Local Institution
-
Pretoria, Gauteng, Südafrika, 0132
- Local Institution
-
-
KWA ZULU Natal
-
Richards Bay, KWA ZULU Natal, Südafrika, 3900
- Local Institution
-
-
Western CAPE
-
Bellville Cape Town, Western CAPE, Südafrika, 7530
- Local Institution
-
George, Western CAPE, Südafrika, 6529
- Local Institution
-
Parow, Western CAPE, Südafrika, 7505
- Local Institution
-
Somerset West, Western CAPE, Südafrika, 7130
- Local Institution
-
Worcester, Western CAPE, Südafrika, 6850
- Local Institution
-
-
-
-
-
Taipei, Taiwan, 100
- Local Institution
-
Taipei, Taiwan, 112
- Local Institution
-
Taipei, Taiwan, 111
- Local Institution
-
Taipei, Taiwan, 220
- Local Institution
-
Taipei, Taiwan, 10449
- Local Institution
-
Taipei, Taiwan, 104
- Local Institution
-
-
-
-
-
Ankara, Truthahn, 06100
- Local Institution
-
Eskisehir, Truthahn, 26480
- Local Institution
-
Izmir, Truthahn, 35100
- Local Institution
-
-
-
-
-
Boskovice, Tschechien, 680 21
- Local Institution
-
Brno, Tschechien, 625 00
- Local Institution
-
Brno-Malomerice, Tschechien, 614 00
- Local Institution
-
Ivancice, Tschechien, 664 91
- Local Institution
-
Kladno, Tschechien, 272 59
- Local Institution
-
Litomysl, Tschechien, 570 14
- Local Institution
-
Mestec Kralove, Tschechien, 289 03
- Local Institution
-
Ostrava, Tschechien, 70852
- Local Institution
-
Prague 13, Tschechien, 158 00
- Local Institution
-
Prague 2, Tschechien, 128 08
- Local Institution
-
Pribram, Tschechien, 261 01
- Local Institution
-
Usti Nad Orlici, Tschechien, 562 18
- Local Institution
-
-
-
-
-
Chernivtsy, Ukraine, 58013
- Local Institution
-
Dnipropetrovsk, Ukraine, 49006
- Local Institution
-
Dnipropetrovsk, Ukraine, 49060
- Local Institution
-
Donetsk, Ukraine, 83045
- Local Institution
-
Donetsk, Ukraine, 83003
- Local Institution
-
Donetsk, Ukraine, 83114
- Local Institution
-
Ivano-Frankivsk, Ukraine, 76025
- Local Institution
-
Kharkiv, Ukraine, 61018
- Local Institution
-
Kharkiv, Ukraine, 61115
- Local Institution
-
Kharkov, Ukraine, 61039
- Local Institution
-
Kharkov, Ukraine, 61002
- Local Institution
-
Kharkov, Ukraine, 61178
- Local Institution
-
Kiev, Ukraine, 01032
- Local Institution
-
Kyiv, Ukraine, 03680
- Local Institution
-
Kyiv, Ukraine, 02091
- Local Institution
-
Kyiv, Ukraine, 03049
- Local Institution
-
Kyiv, Ukraine, 03115
- Local Institution
-
Kyiv, Ukraine, 04050
- Local Institution
-
Kyiv, Ukraine, 04107
- Local Institution
-
Kyiv, Ukraine, 01023
- Local Institution
-
Kyiv, Ukraine, 02660
- Local Institution
-
Kyiv, Ukraine, 01103
- Local Institution
-
Lugansk, Ukraine, 91011
- Local Institution
-
Lugansk, Ukraine, 91016
- Local Institution
-
Lutsk, Ukraine, 43024
- Local Institution
-
Lviv, Ukraine, 79013
- Local Institution
-
Lviv, Ukraine, 79015
- Local Institution
-
Mykolayiv, Ukraine, 54003
- Local Institution
-
Odessa, Ukraine, 65009
- Local Institution
-
Odessa, Ukraine, 65039
- Local Institution
-
Odessa, Ukraine, 65114
- Local Institution
-
Odessa, Ukraine, 65025
- Local Institution
-
Uzhgorod, Ukraine, 88000
- Local Institution
-
Vinnitsa, Ukraine, 21029
- Local Institution
-
Zaporozhye, Ukraine, 69035
- Local Institution
-
Zhytomyr, Ukraine, 10002
- Local Institution
-
-
-
-
-
Budapest, Ungarn, 1125
- Local Institution
-
Budapest, Ungarn, 1023
- Local Institution
-
Budapest, Ungarn, 1032
- Local Institution
-
Budapest, Ungarn, 1096
- Local Institution
-
Budapest, Ungarn, 1085
- Local Institution
-
Debrecen, Ungarn, 4032
- Local Institution
-
Dunaujvaros, Ungarn, 2400
- Local Institution
-
Gyor, Ungarn, 9023
- Local Institution
-
Gyula, Ungarn, 5700
- Local Institution
-
Hodmezovasarhely, Ungarn, 6800
- Local Institution
-
Komarom, Ungarn, 2921
- Local Institution
-
Mosonmagyarovar, Ungarn, 9200
- Local Institution
-
Oroshaza, Ungarn, 5900
- Local Institution
-
Pecs, Ungarn, 7624
- Local Institution
-
Siofok, Ungarn, 8600
- Local Institution
-
Siofok, Ungarn, 8601
- Local Institution
-
Sopron, Ungarn, 9400
- Local Institution
-
Szentes, Ungarn, 6600
- Local Institution
-
Zalaegerszeg, Ungarn, 8900
- Local Institution
-
-
-
-
Alabama
-
Birmingham, Alabama, Vereinigte Staaten, 35209
- Cardiovascular Associates, Pc
-
Birmingham, Alabama, Vereinigte Staaten, 35235
- Alabama Internal Medicine Pc
-
Birmingham, Alabama, Vereinigte Staaten, 35235
- Birmingham Heart Clinic P.C.
-
Huntsville, Alabama, Vereinigte Staaten, 35801
- Heart Center, Inc.
-
Mobile, Alabama, Vereinigte Staaten, 36608
- Mobile Heart Specialists, PC
-
Mobile, Alabama, Vereinigte Staaten, 36617
- Clara V. Massey, Md
-
-
Alaska
-
Anchorage, Alaska, Vereinigte Staaten, 99508
- Alaska Heart Institute
-
-
Arizona
-
Phoenix, Arizona, Vereinigte Staaten, 85006
- Internal Medicine Physicians Associates, P.C.
-
Tucson, Arizona, Vereinigte Staaten, 85723
- Southern Arizona VA Health Care System
-
Tucson, Arizona, Vereinigte Staaten, 85710
- Southwest Heart
-
Tucson, Arizona, Vereinigte Staaten, 85745
- Pima Research Foundation
-
-
Arkansas
-
Hot Springs, Arkansas, Vereinigte Staaten, 71913
- Dr. Rajesh Shroff
-
Little Rock, Arkansas, Vereinigte Staaten, 72204
- Mary K. Richards, Md Pa
-
-
California
-
Anaheim, California, Vereinigte Staaten, 92801
- Advanced Clinical Reserach Institute
-
Beverly Hills, California, Vereinigte Staaten, 90210
- Act/Cardiovascular Research Institute
-
Carmichael, California, Vereinigte Staaten, 95608
- Capitol Interventional Cardiology
-
Escondido, California, Vereinigte Staaten, 92025
- Escondido Cardiology Associates, Inc.
-
Healdsburg, California, Vereinigte Staaten, 95448
- William D. Bowden, D.O.
-
La Mesa, California, Vereinigte Staaten, 91942
- La Mesa Cardiac Center, A Medical Group
-
Los Angeles, California, Vereinigte Staaten, 90073
- VA Greater Los Angeles Healthcare System
-
Mission Viejo, California, Vereinigte Staaten, 92691
- Coastal Cardiology
-
Oceanside, California, Vereinigte Staaten, 92056
- Kenneth W. Carr Md
-
Palm Springs, California, Vereinigte Staaten, 92262
- Desert Med Grp Inc, Dba Desert Oasis Healthcare Med Group
-
Rancho Mirage, California, Vereinigte Staaten, 92270
- Desert Cardiology Consultants Medical Group, Inc
-
Sacramento, California, Vereinigte Staaten, 95821
- Northern California Research
-
Sacramento, California, Vereinigte Staaten, 95825
- Sacramento Heart And Vascular Medical Associates
-
Sacramento, California, Vereinigte Staaten, 95819
- Regional Cardiolody Associates
-
Santa Barbara, California, Vereinigte Staaten, 93105
- Arrhythmia Consultants Of The Central Coast Medical Group
-
Santa Rosa, California, Vereinigte Staaten, 95403
- Northern California Medical Associates
-
Vista, California, Vereinigte Staaten, 92083
- Progressive Clinical Research
-
Walnut Creek, California, Vereinigte Staaten, 94598
- Cardivasclular Consultants Medical Group
-
Wildomar, California, Vereinigte Staaten, 92595
- Shiva Heart Center Medical Group
-
-
Colorado
-
Colorado Springs, Colorado, Vereinigte Staaten, 80910
- Electrophysiology Associates, Pc
-
Denver, Colorado, Vereinigte Staaten, 80220
- Denver VA Medical Center
-
Denver, Colorado, Vereinigte Staaten, 80218
- Aurora Denver Cardiology Associates, P.C.
-
Golden, Colorado, Vereinigte Staaten, 80401
- New West Physicians Clinical Research
-
Littleton, Colorado, Vereinigte Staaten, 80120
- South Denver Cardiology Associates PC
-
-
Connecticut
-
Bridgeport, Connecticut, Vereinigte Staaten, 06610
- Bridgeport Hospital
-
Bridgeport, Connecticut, Vereinigte Staaten, 06606
- Connecticut Clinical Research, Llc
-
Guilford, Connecticut, Vereinigte Staaten, 06437
- Cardiology Associates Of New Haven,Pc
-
Norwich, Connecticut, Vereinigte Staaten, 06360
- William W Backus Hospital
-
Norwich, Connecticut, Vereinigte Staaten, 06360
- The William W. Backus Hospital
-
Stamford, Connecticut, Vereinigte Staaten, 06905
- Stamford Therapeutics Consortium
-
Waterbury, Connecticut, Vereinigte Staaten, 06708
- Chase Medical Research, LLC
-
-
Delaware
-
Newark, Delaware, Vereinigte Staaten, 19713
- Alfieri Cardiology
-
-
District of Columbia
-
Washington, District of Columbia, Vereinigte Staaten, 20422
- Washington VA Medical Center
-
Washington, District of Columbia, Vereinigte Staaten, 20037
- George Washington University Medical Faculty Associates
-
-
Florida
-
Atlantis, Florida, Vereinigte Staaten, 33462
- Medical Specialist Of The Palm Beach
-
Aventura, Florida, Vereinigte Staaten, 33180
- Miami International Cardiology Consultants
-
Boca Raton, Florida, Vereinigte Staaten, 33431
- David Charles Mishkel, Md, Pa
-
Clearwater, Florida, Vereinigte Staaten, 33756
- The Heart & Vascular Institute Of Florida
-
Clearwater, Florida, Vereinigte Staaten, 33756
- The Heart And Vascular Institute Of Florida
-
Davie, Florida, Vereinigte Staaten, 33324
- Cardiovascular Specialist Of South Florida
-
Daytona Beach, Florida, Vereinigte Staaten, 32114
- Daytona Heart Group
-
Fort Lauderdale, Florida, Vereinigte Staaten, 33316
- Broward General Medical Center
-
Fort Lauderdale, Florida, Vereinigte Staaten, 33308
- Cardiology Associates Of Fort Lauderdale, P.A.
-
Fort Myers, Florida, Vereinigte Staaten, 33907
- Florida Heart Associates
-
Gainesville, Florida, Vereinigte Staaten, 32605
- Florida Research Network, LLC
-
Hollywood, Florida, Vereinigte Staaten, 33021
- Healthworx
-
Hollywood, Florida, Vereinigte Staaten, 33021
- Luis Tami, Md
-
Inverness, Florida, Vereinigte Staaten, 34452
- Nature Coast Clinical Research
-
Jacksonville, Florida, Vereinigte Staaten, 32216
- Jacksonville Center for Clinical Research
-
Jacksonville, Florida, Vereinigte Staaten, 32216
- Jacksonville Cardiovascular Center
-
Jacksonville, Florida, Vereinigte Staaten, 32258
- Jacksonville Heart Center, Pa
-
Jacksonville, Florida, Vereinigte Staaten, 32204
- St. Vincent'S Ambulatory Care, Inc
-
Jacksonville, Florida, Vereinigte Staaten, 32207
- Jacksonville Heart Center, Pa
-
Jacksonville, Florida, Vereinigte Staaten, 32216
- St. Luke'S Cardiology
-
Jacksonville Beach, Florida, Vereinigte Staaten, 32250
- Jacksonville Heart Center, P.A.
-
Jupiter, Florida, Vereinigte Staaten, 33458
- Cvms Research Institute, Llc
-
Jupiter, Florida, Vereinigte Staaten, 33458
- Ricardo Bedoya, M.D.
-
Melbourne, Florida, Vereinigte Staaten, 32901
- Melbourne Internal Medicine Associates
-
Miami, Florida, Vereinigte Staaten, 33137
- Miami International Cardiology Consultants
-
Miami, Florida, Vereinigte Staaten, 33137-3732
- Miami International Cardiology Consultants
-
Naples, Florida, Vereinigte Staaten, 34119
- Physicians Regional Medical Group
-
Orlando, Florida, Vereinigte Staaten, 32803
- Florida Heart Group
-
Oviedo, Florida, Vereinigte Staaten, 32765
- Alpha Medical Research
-
Pensacola, Florida, Vereinigte Staaten, 32501
- Cardiology Consultants
-
Saint Petersburg, Florida, Vereinigte Staaten, 33709
- The Heart And Vascular Institute Of Florida
-
Sarasota, Florida, Vereinigte Staaten, 34239
- Heart & Vascular Center Research, Inc.
-
Sarasota, Florida, Vereinigte Staaten, 34232
- Niranjan Seshadri, Md
-
Vero Beach, Florida, Vereinigte Staaten, 32960
- Research, Inc.
-
-
Georgia
-
Atlanta, Georgia, Vereinigte Staaten, 30342
- Cardiovascular Specialits, Pc
-
Augusta, Georgia, Vereinigte Staaten, 30901
- Augusta Cardiology Clinic, P.C.
-
Columbus, Georgia, Vereinigte Staaten, 31909
- Columbus Cardiology Associates Pc
-
Columbus, Georgia, Vereinigte Staaten, 31909
- Columbus Cardiology Associates,Pc
-
Covington, Georgia, Vereinigte Staaten, 30014
- Georgia Heart Specialists, L.L.C.
-
Decatur, Georgia, Vereinigte Staaten, 30030
- Atlanta Institute For Medical Research, Inc
-
Gainesville, Georgia, Vereinigte Staaten, 30501
- Northeast Georgia Heart Center, PC
-
Marietta, Georgia, Vereinigte Staaten, 30060
- Wellstar Cardiovascular Medicine, Pc
-
-
Illinois
-
Aurora, Illinois, Vereinigte Staaten, 60504
- Fox Valley Clinical Research Center, LLC
-
Chicago, Illinois, Vereinigte Staaten, 60611
- Nmff
-
Gurnee, Illinois, Vereinigte Staaten, 60031
- Clinical Investigation Specialists, Inc
-
Maywood, Illinois, Vereinigte Staaten, 60153
- Loyola University Medical Center
-
Normal, Illinois, Vereinigte Staaten, 61761
- Illinois Heart & Lung Research Center, Sc
-
North Chicago, Illinois, Vereinigte Staaten, 60064
- Cpt. James A Lovell Federal Health Care Center
-
-
Indiana
-
Anderson, Indiana, Vereinigte Staaten, 46011
- Community Clinical Research Center
-
Bloomington, Indiana, Vereinigte Staaten, 47403
- Premier Healthcare, Llc
-
Elkhart, Indiana, Vereinigte Staaten, 46514
- Elkhart Clinic, LLC
-
Fort Wayne, Indiana, Vereinigte Staaten, 46804
- Lutheran Medical Group, Llc
-
Fort Wayne, Indiana, Vereinigte Staaten, 46805
- Fort Wayne Cardiology
-
Indianapolis, Indiana, Vereinigte Staaten, 46290
- The Care Group, Llc
-
Indianapolis, Indiana, Vereinigte Staaten, 46290
- The Care Group, Llc.
-
Indianapolis, Indiana, Vereinigte Staaten, 46237
- St Francis Medical Group - Indiana Heart Physicians
-
Michigan City, Indiana, Vereinigte Staaten, 46360
- Dali, Sammi
-
South Bend, Indiana, Vereinigte Staaten, 46601
- Cardiology Associates, Inc.
-
-
Iowa
-
Ames, Iowa, Vereinigte Staaten, 50010
- McFarland Clinic PC
-
-
Kansas
-
Overland Park, Kansas, Vereinigte Staaten, 66209
- Midwest Cardiology Associates , P.C.
-
-
Kentucky
-
Elizabethtown, Kentucky, Vereinigte Staaten, 42701
- Central Cardiology Assoc.
-
Lexington, Kentucky, Vereinigte Staaten, 40504
- New Lexington Clinic, P.S.C.
-
Louisville, Kentucky, Vereinigte Staaten, 40205
- Norton Cardiovascular Associates
-
Louisville, Kentucky, Vereinigte Staaten, 40202
- VA Medical Center
-
Owensboro, Kentucky, Vereinigte Staaten, 42303
- Owensboro Heart & Vascular
-
-
Louisiana
-
Alexandria, Louisiana, Vereinigte Staaten, 71301
- Alexandria Cardiology Clinic
-
Houma, Louisiana, Vereinigte Staaten, 70360
- Cardiovascular Institute of the South
-
Lacombe, Louisiana, Vereinigte Staaten, 70445
- Smith, Patel & Amkieh, Llc
-
Lake Charles, Louisiana, Vereinigte Staaten, 70601
- Imperial Calcasieu Medical Group, Llp
-
Marrero, Louisiana, Vereinigte Staaten, 70072
- Cardiology Center, Llc
-
Shreveport, Louisiana, Vereinigte Staaten, 71105
- Cardiology Associates
-
Slidell, Louisiana, Vereinigte Staaten, 70458
- Louisiana Heart Center
-
Slidell, Louisiana, Vereinigte Staaten, 70458
- Medical Research Inst, Inc
-
Slidell, Louisiana, Vereinigte Staaten, 70458
- Medical Research Institute, Inc
-
Ventura, Louisiana, Vereinigte Staaten, 93003
- Ventura Cardio. Cond. Med. Group, Inc.
-
-
Maine
-
Lewiston, Maine, Vereinigte Staaten, 04240
- Central Maine Heart & Vascular Institute
-
-
Maryland
-
Baltimore, Maryland, Vereinigte Staaten, 21224
- Johns Hopkins Bayview Medical Center
-
Baltimore, Maryland, Vereinigte Staaten, 21237
- Franklin Square Hospital
-
Baltimore, Maryland, Vereinigte Staaten, 21208
- Midatlantic Cardiovascular Associates, Pa
-
Baltimore, Maryland, Vereinigte Staaten, 21237
- Midatlantic Cardiovascular Associates, Pa
-
Baltimore, Maryland, Vereinigte Staaten, 21204
- Midatlantic Cardiovascular Associates, P.A.
-
Baltimore, Maryland, Vereinigte Staaten, 21218
- Midatlantic Cardiovascular Associates, P.A.
-
Baltimore, Maryland, Vereinigte Staaten, 21224-2735
- Johns Hopkins Bayview Medical Center
-
Baltimore, Maryland, Vereinigte Staaten, 21237
- Midatlantic Cardiovascular Associates, P.A.
-
Bel Air, Maryland, Vereinigte Staaten, 21014
- Midatlantic Cardiovascular Associates, Pa
-
Columbia, Maryland, Vereinigte Staaten, 21044
- Cardiovascular Specialists Of Central Maryland, P.A.
-
Reisterstown, Maryland, Vereinigte Staaten, 21136
- Clinical Associates Research
-
Westminster, Maryland, Vereinigte Staaten, 21157
- Midatlantic Cardiovascular Associates, Pa
-
-
Massachusetts
-
Billerica, Massachusetts, Vereinigte Staaten, 01821
- Burlington Medical Associates
-
Boston, Massachusetts, Vereinigte Staaten, 02135
- Caritas St. Elizabeth's Medical Center
-
Burlington, Massachusetts, Vereinigte Staaten, 01805
- Lahey Clinic Medical Center
-
Fall River, Massachusetts, Vereinigte Staaten, 02720
- Neccr Internal Medicine & Cardiology Associates,Llc
-
Haverhill, Massachusetts, Vereinigte Staaten, 01830
- Pentucket Medical Associates
-
Haverhill, Massachusetts, Vereinigte Staaten, 01830-6278
- Pentucket Medical Associates
-
Natick, Massachusetts, Vereinigte Staaten, 01760
- Charles River Medical Associates
-
-
Michigan
-
Alpena, Michigan, Vereinigte Staaten, 49707
- Great Lakes Heart Center Of Alpena
-
Detroit, Michigan, Vereinigte Staaten, 48202
- Henry Ford Hospital
-
Lansing, Michigan, Vereinigte Staaten, 48910
- Thoracic And Cardiovascular Healthcare Foundation
-
Livonia, Michigan, Vereinigte Staaten, 48154
- Advanced Cardiovascular Health Specialists, Pc
-
Petoskey, Michigan, Vereinigte Staaten, 49770
- Michigan Heart And Vascular Specialists
-
Royal Oak, Michigan, Vereinigte Staaten, 48073
- William Beaumont Hospital
-
Ypsilanti, Michigan, Vereinigte Staaten, 48197
- Michigan Heart, P.C.
-
-
Minnesota
-
Minneapolis, Minnesota, Vereinigte Staaten, 55455
- University of Minnesota
-
Minneapolis, Minnesota, Vereinigte Staaten, 55417
- Minneapolis VA Medical Center
-
Robbinsdale, Minnesota, Vereinigte Staaten, 55422
- North Memorial Health Care
-
-
Mississippi
-
Olive Branch, Mississippi, Vereinigte Staaten, 38654
- Olive Branch Family Medical Center
-
Tupelo, Mississippi, Vereinigte Staaten, 38801
- Tupelo Neurology Clinic, Pa
-
-
Missouri
-
Columbia, Missouri, Vereinigte Staaten, 65212
- University of Missouri
-
Kansas City, Missouri, Vereinigte Staaten, 64108
- Truman Medical Center
-
Kansas City, Missouri, Vereinigte Staaten, 64111
- Saint Luke's Lipid and Diabetes Research Center
-
-
Nebraska
-
Grand Island, Nebraska, Vereinigte Staaten, 68803
- Internal Medical Associates Of Grand Island, P.C
-
Grand Island, Nebraska, Vereinigte Staaten, 68803-4311
- Internal Medical Associates Of Grand Island, P.C
-
Hastings, Nebraska, Vereinigte Staaten, 68901
- Nebraska Heart Institute
-
-
Nevada
-
Las Vegas, Nevada, Vereinigte Staaten, 89106
- VA Southern Nevada Healthcare System
-
-
New Jersey
-
Berlin, New Jersey, Vereinigte Staaten, 08009
- Comprehensive Clinical Research
-
Elmer, New Jersey, Vereinigte Staaten, 08318
- Cardiovascular Associates Of The Delware Valley, P.A.
-
Haddon Heights, New Jersey, Vereinigte Staaten, 08035
- Cardiovascular Associates Of The Delaware Valley, P.A.
-
Princeton, New Jersey, Vereinigte Staaten, 08540
- Princeton Medical Institute
-
Sewell, New Jersey, Vereinigte Staaten, 08080
- Cardio Assoc Of Del Val, P.A.
-
South Plainfield, New Jersey, Vereinigte Staaten, 07080
- Central New Jersey Cardiology
-
-
New Mexico
-
Albuquerque, New Mexico, Vereinigte Staaten, 87012
- Abq Health Partners, Llc
-
Albuquerque, New Mexico, Vereinigte Staaten, 87131-0001
- University Of New Mexico/University Hospital
-
Albuquerque, New Mexico, Vereinigte Staaten, 87131
- University Of New Mexico/University Hospital
-
-
New York
-
Albany, New York, Vereinigte Staaten, 12205
- Albany Associates In Cardiology
-
Albany, New York, Vereinigte Staaten, 12205
- Albany Assoc. In Cardiology
-
Binghamton, New York, Vereinigte Staaten, 13905
- Cardiology Associates, Pc
-
Buffalo, New York, Vereinigte Staaten, 14215
- Buffalo Heart Group, LLP
-
Buffalo, New York, Vereinigte Staaten, 14215-1145
- Buffalo Heart Group, LLP
-
Buffalo, New York, Vereinigte Staaten, 14215
- Bruce L. Platt Md, Pc
-
Buffalo, New York, Vereinigte Staaten, 14215
- Bruce L. Platt, Md
-
East Syracuse, New York, Vereinigte Staaten, 13057
- Heart Care Center, P.C.
-
Huntington, New York, Vereinigte Staaten, 11743
- Huntington Hospital
-
Liverpool, New York, Vereinigte Staaten, 13088
- SJH Cardiology Associates
-
Mineola, New York, Vereinigte Staaten, 11501
- Long Island Heart Associates
-
Saratoga Springs, New York, Vereinigte Staaten, 12866
- Saratoga Cardiology Associates, Pc
-
Williamsville, New York, Vereinigte Staaten, 14221
- Office Of Dr. Kozinn
-
Williamsville, New York, Vereinigte Staaten, 14221
- Suburban Cardiology
-
-
North Carolina
-
Asheville, North Carolina, Vereinigte Staaten, 28803
- Asheville Cardiology Associates
-
Burlington, North Carolina, Vereinigte Staaten, 27215
- Kernodle Clinic, Inc.
-
High Point, North Carolina, Vereinigte Staaten, 27262
- Carolina Cardiology Associates, Pa
-
Pinehurst, North Carolina, Vereinigte Staaten, 28374
- Pinehurst Medical Center, Inc
-
-
North Dakota
-
Fargo, North Dakota, Vereinigte Staaten, 58103
- Lillestol Research LLC
-
-
Ohio
-
Akron, Ohio, Vereinigte Staaten, 44304
- Akron Cardiology Consultants
-
Bucyrus, Ohio, Vereinigte Staaten, 44820
- Christopher M. Johnson, D.O.
-
Bucyrus, Ohio, Vereinigte Staaten, OHIO
- Christopher M. Johnson, D.O.
-
Canal Fulton, Ohio, Vereinigte Staaten, 44614
- Community Health Care, Inc.
-
Canton, Ohio, Vereinigte Staaten, 44710
- Cardiology Associates
-
Cincinnati, Ohio, Vereinigte Staaten, 45219
- The Carl & Edyth Lindner Center For R&E At The Christ Hosp
-
Toledo, Ohio, Vereinigte Staaten, 43608
- Toledo Cardiology Consultants
-
Wadsworth, Ohio, Vereinigte Staaten, 44281
- Family Practice Center of Wadsworth, Inc.
-
-
Oklahoma
-
Muskogee, Oklahoma, Vereinigte Staaten, 74401
- Jack C. Va Medical Center
-
Oklahoma City, Oklahoma, Vereinigte Staaten, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, Vereinigte Staaten, 73112
- Plaza Medical Group, Pc
-
Oklahoma City, Oklahoma, Vereinigte Staaten, 73103
- COR Clinical Research, LLC
-
Oklahoma City, Oklahoma, Vereinigte Staaten, 73135
- South Oklahoma Heart Research
-
Oklahoma City, Oklahoma, Vereinigte Staaten, 73120
- Oklahoma Heart Hospital Physicians
-
Oklahoma City, Oklahoma, Vereinigte Staaten, 73139
- Eminence Research, LLC
-
Tulsa, Oklahoma, Vereinigte Staaten, 74136
- Castlerock Clinical Research Consultants, Llc
-
-
Oregon
-
Bend, Oregon, Vereinigte Staaten, 97701
- St. Charles Health System, Inc.
-
Bend, Oregon, Vereinigte Staaten, 97701
- St. Charles Health System, Inc
-
Eugene, Oregon, Vereinigte Staaten, 97401
- Oregon Medical Group - Clinical Research
-
Hillsboro, Oregon, Vereinigte Staaten, 97123
- Hillsboro Cardiology Pc
-
Medford, Oregon, Vereinigte Staaten, 97504
- Rogue Valley Physicians - Clinical Research Group
-
-
Pennsylvania
-
Abington, Pennsylvania, Vereinigte Staaten, 19001
- Abington Medical Specialists
-
Altoona, Pennsylvania, Vereinigte Staaten, 16602
- Blair Medical Associates, Inc.
-
Camp Hill, Pennsylvania, Vereinigte Staaten, 17011
- Heritage Cardiology Assoc.
-
Doylestown, Pennsylvania, Vereinigte Staaten, 18901
- Central Bucks Cardiology
-
Erie, Pennsylvania, Vereinigte Staaten, 16509
- Internal Medicine And Lipid Mgmt.
-
Harrisburg, Pennsylvania, Vereinigte Staaten, 17112
- Kandra, Fierer, Kuskin Associates
-
Hatfield, Pennsylvania, Vereinigte Staaten, 19440
- Pivotal Clinical Research, Llc
-
Jersey Shore, Pennsylvania, Vereinigte Staaten, 17740
- Lycoming Internal Medicine Inc.
-
Sayre, Pennsylvania, Vereinigte Staaten, 18840
- Guthrie Medical Group, P.C.
-
Sayre, Pennsylvania, Vereinigte Staaten, 18840
- Guthrie Clinic Ltd.
-
Uniontown, Pennsylvania, Vereinigte Staaten, 15401
- Preferred Primary Care Physicians
-
West Chester, Pennsylvania, Vereinigte Staaten, 19380
- West Chester Cardiology, Pc
-
Yardley, Pennsylvania, Vereinigte Staaten, 19067
- Cardiology Consultants of Philadelphia
-
-
Rhode Island
-
Providence, Rhode Island, Vereinigte Staaten, 02903
- Rhode Island Hospital
-
-
South Carolina
-
Anderson, South Carolina, Vereinigte Staaten, 29621
- Southeastern Research Associates, Inc
-
Beaufort, South Carolina, Vereinigte Staaten, 29906
- Lowcountry Medical Group, Llc
-
Beaufort, South Carolina, Vereinigte Staaten, 29906
- Lowcountry Medical Group
-
Charleston, South Carolina, Vereinigte Staaten, 29425
- Medical University of South Carolina
-
Columbia, South Carolina, Vereinigte Staaten, 29203
- Columbia Heart Clinic
-
Greenville, South Carolina, Vereinigte Staaten, 29607
- Upstate Cardiology
-
Greer, South Carolina, Vereinigte Staaten, 29650
- Internal Medicine Of Greer
-
Orangeburg, South Carolina, Vereinigte Staaten, 29118
- Palmetto Nephrology Pa
-
Spartanburg, South Carolina, Vereinigte Staaten, 29303
- S. Carolina Pharmaceutical Research
-
-
South Dakota
-
Pierre, South Dakota, Vereinigte Staaten, 57501
- Avera Medical Associates Clinic
-
-
Tennessee
-
Bristol, Tennessee, Vereinigte Staaten, 37620
- Holston Medical Group
-
Kingsport, Tennessee, Vereinigte Staaten, 37660
- Holston Medical Group
-
Knoxville, Tennessee, Vereinigte Staaten, 37920
- Volunteer Research Group
-
Knoxville, Tennessee, Vereinigte Staaten, 37916
- Knoxville Heart Group
-
Knoxville, Tennessee, Vereinigte Staaten, 37920-1502
- Volunteer Research Group
-
Tullahoma, Tennessee, Vereinigte Staaten, 37388
- Tennessee Center for Clinical Trials
-
-
Texas
-
Amarillo, Texas, Vereinigte Staaten, 79106
- Amarillo Heart Clinical Research Institute Inc.
-
Corsicana, Texas, Vereinigte Staaten, 75110
- Corsicana Medical Research, PLLC
-
Dallas, Texas, Vereinigte Staaten, 75226
- Soltero Cardiovascular Research Center
-
Dallas, Texas, Vereinigte Staaten, 75230
- HeartPlace
-
Fort Worth, Texas, Vereinigte Staaten, 76104
- Heart Center of North Texas
-
Houston, Texas, Vereinigte Staaten, 77030
- The Methodist Hospital
-
Houston, Texas, Vereinigte Staaten, 77030
- The University of Texas MD Anderson Cancer Center
-
Houston, Texas, Vereinigte Staaten, 77030
- Center For Atrial Fibrillation
-
Houston, Texas, Vereinigte Staaten, 77030
- The Methodist Hospital Neurology Institute
-
Houston, Texas, Vereinigte Staaten, 77065
- Northwest Houston Cardiology, Pa
-
Houston, Texas, Vereinigte Staaten, 77070
- Northwest Houston Cardiology, Pa
-
Houston, Texas, Vereinigte Staaten, 77074
- Francisco R. Maislos
-
Houston, Texas, Vereinigte Staaten, 77090
- Woodlands North Houston Heart Center
-
Humble, Texas, Vereinigte Staaten, 77338
- Regional Medical Center And Diagnostic Clinics
-
Lackland Air Force Base, Texas, Vereinigte Staaten, 78236
- Wilford Hall Medical Center
-
Lackland Air Force Base, Texas, Vereinigte Staaten, 78236-9908
- Wilford Hall Medical Center
-
Longview, Texas, Vereinigte Staaten, 75605
- DCOL Center for Clinical Research
-
McKinney, Texas, Vereinigte Staaten, 75069
- North Dallas Research Associates
-
Plano, Texas, Vereinigte Staaten, 75093
- North Texas Medical Research
-
Plano, Texas, Vereinigte Staaten, 75024
- Legacy Heart Center
-
San Antonio, Texas, Vereinigte Staaten, 78229
- Covenant Clinical Research, Pa
-
San Antonio, Texas, Vereinigte Staaten, 78217
- Bhs Specialty Network, Inc
-
San Antonio, Texas, Vereinigte Staaten, 78229
- Star Clinical Trails
-
Seguin, Texas, Vereinigte Staaten, 78155
- Edward Balli, Md, Pa
-
Tomball, Texas, Vereinigte Staaten, 77375
- Northwest Heart Center
-
Tyler, Texas, Vereinigte Staaten, 75701
- Tyler Cardiovascular Consultants
-
Tyler, Texas, Vereinigte Staaten, 75708
- University of Texas Health Science Center at Tyler
-
Tyler, Texas, Vereinigte Staaten, 75708
- The Univ. Of Texas Health Science Ctr. At Tyler
-
-
Utah
-
Layton, Utah, Vereinigte Staaten, 84041
- Utah Cardiology P.C
-
-
Virginia
-
Norfolk, Virginia, Vereinigte Staaten, 23510
- Sentara York Clinical Research
-
Richmond, Virginia, Vereinigte Staaten, 23220
- Medical Research Initiatives
-
Roanoke, Virginia, Vereinigte Staaten, 24014
- Roanoke Heart Institute, Plc
-
Virginia Beach, Virginia, Vereinigte Staaten, 23454
- Cardiovascular Associates
-
-
Washington
-
Burien, Washington, Vereinigte Staaten, 98166
- Daniel W. Gottlieb, Md, Ps
-
Burien, Washington, Vereinigte Staaten, 98166
- Daniel William Gottlieb, Md
-
Spokane, Washington, Vereinigte Staaten, 99202
- Rockwood Clinic Research Cent.
-
Walla Walla, Washington, Vereinigte Staaten, 99362
- Walla Walla Clinic
-
-
West Virginia
-
Lewisburg, West Virginia, Vereinigte Staaten, 24901
- Lynn N. Smith, Md
-
-
Wisconsin
-
Green Bay, Wisconsin, Vereinigte Staaten, 54301
- Cardiology Associates Of Green Bay Ltd-Bellin Hospital
-
Madison, Wisconsin, Vereinigte Staaten, 53715
- St. Mary's Hospital
-
Madison, Wisconsin, Vereinigte Staaten, 53715
- St.Mary's Hospital
-
Milwaukee, Wisconsin, Vereinigte Staaten, 53226
- Medical College of Wisconsin
-
Milwaukee, Wisconsin, Vereinigte Staaten, 53215
- Aurora Health Care
-
Waukesha, Wisconsin, Vereinigte Staaten, 53188
- Cardiology Assc. Of Waukesha
-
-
-
-
-
Antrim, Vereinigtes Königreich, BT41 2RL
- Local Institution
-
Blackpool, Vereinigtes Königreich, FY3 8NR
- Local Institution
-
Glasgow, Vereinigtes Königreich, G21 3UW
- Local Institution
-
-
Aberdeenshire
-
Aberdeen, Aberdeenshire, Vereinigtes Königreich, AB25 2ZN
- Local Institution
-
Glasgow, Aberdeenshire, Vereinigtes Königreich, G11 6NT
- Local Institution
-
-
Antrim
-
Belfast, Antrim, Vereinigtes Königreich, BT14 6AB
- Local Institution
-
-
Armagh
-
Craigavon, Armagh, Vereinigtes Königreich, BT63 5QQ
- Local Institution
-
-
Cambridgeshire
-
Cambridge, Cambridgeshire, Vereinigtes Königreich, CB2 2QQ
- Local Institution
-
Peterborough, Cambridgeshire, Vereinigtes Königreich, PE2 5GP
- Local Institution
-
-
Derbyshire
-
Chesterfield, Derbyshire, Vereinigtes Königreich, S44 5BL
- Local Institution
-
Chesterfield, Derbyshire, Vereinigtes Königreich, S40 4TF
- Local Institution
-
-
Dorset
-
Bournemouth, Dorset, Vereinigtes Königreich, BH7 7DW
- Local Institution
-
-
Dumbartonshire
-
Glasgow, Dumbartonshire, Vereinigtes Königreich, G11 6NT
- Local Institution
-
-
EAST Sussex
-
Chichester, EAST Sussex, Vereinigtes Königreich, PO19 6SE
- Local Institution
-
-
Essex
-
Colchester, Essex, Vereinigtes Königreich, C03 4LN
- Local Institution
-
Romford, Essex, Vereinigtes Königreich, RH7 0AG
- Local Institution
-
-
Greater London
-
Denmark Hill, Greater London, Vereinigtes Königreich, SE5 9RS
- Local Institution
-
London, Greater London, Vereinigtes Königreich, SW17 0RE
- Local Institution
-
-
Gwent
-
Newport, Gwent, Vereinigtes Königreich, NP20 2UB
- Local Institution
-
-
Hertfordshire
-
Barnet, Hertfordshire, Vereinigtes Königreich, EN5 3DJ
- Local Institution
-
-
MID Glamorgan
-
Cardiff, MID Glamorgan, Vereinigtes Königreich, CF14 4XW
- Local Institution
-
Llandough, MID Glamorgan, Vereinigtes Königreich, CF64 2XX
- Local Institution
-
-
Middlesex
-
Harrow, Middlesex, Vereinigtes Königreich, HA1 3UJ
- Local Institution
-
-
Nottinghamshire
-
Nottingham, Nottinghamshire, Vereinigtes Königreich, NG5 1PB
- Local Institution
-
Worksop, Nottinghamshire, Vereinigtes Königreich, S81 OBD
- Local Institution
-
-
Renfrewshire
-
Paisley, Renfrewshire, Vereinigtes Königreich, PA2 9PN
- Local Institution
-
-
South Yorkshire
-
Barnsley, South Yorkshire, Vereinigtes Königreich, S75 2EP
- Local Institution
-
Doncaster, South Yorkshire, Vereinigtes Königreich, DN2 5LT
- Local Institution
-
-
Stirlingshire
-
Stirling, Stirlingshire, Vereinigtes Königreich, FK8 2AU
- Local Institution
-
-
Strathclyde
-
Glasgow, Strathclyde, Vereinigtes Königreich, G51 4TF
- Local Institution
-
-
Suffolk
-
Bury St Edmunds, Suffolk, Vereinigtes Königreich, IP31 2HD
- Local Institution
-
Bury St Edmunds, Suffolk, Vereinigtes Königreich, IP33 2QZ
- Local Institution
-
Bury St. Edmunds, Suffolk, Vereinigtes Königreich, IP30 9QU
- Local Institution
-
Ipswich, Suffolk, Vereinigtes Königreich, IP14 2PU
- Local Institution
-
Ipswich, Suffolk, Vereinigtes Königreich, IP7 5DN
- Local Institution
-
-
Tyne and Wear
-
Newcastle Upon Tyne, Tyne and Wear, Vereinigtes Königreich, NE1 4LP
- Local Institution
-
-
WEST Glamorgan
-
Swansea, WEST Glamorgan, Vereinigtes Königreich, SA6 6NL
- Local Institution
-
-
WEST Lothian
-
Livingston, WEST Lothian, Vereinigtes Königreich, EH54 6PP
- Local Institution
-
-
WEST Midlands
-
Birmingham, WEST Midlands, Vereinigtes Königreich, B18 7QH
- Local Institution
-
-
Wiltshire
-
Westbury, Wiltshire, Vereinigtes Königreich, BA 13 3JD
- Local Institution
-
Westbury, Wiltshire, Vereinigtes Königreich, BA13 3JD
- Local Institution
-
-
Yorkshire
-
York, Yorkshire, Vereinigtes Königreich, YO31 8HE
- Local Institution
-
York, Yorkshire, Vereinigtes Königreich, YO31 HE
- Local Institution
-
-
-
-
-
Graz, Österreich, 8036
- Local Institution
-
Oberpullendorf, Österreich, 7350
- Local Institution
-
Vienna, Österreich, 1160
- Local Institution
-
-
Teilnahmekriterien
Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.
Zulassungskriterien
Studienberechtigtes Alter
- Kind
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Nein
Studienberechtigte Geschlechter
Alle
Beschreibung
Inclusion Criteria:
- Males and females ≥ 18 yrs with atrial fibrillation (AF) and one or more of the following risk factors for stroke:
- Age ≥ 75, previous stroke
- transient ischemic attack (TIA) or Systemic Embolism (SE)
- Symptomatic congestive heart failure or left ventricular dysfunction with left ventricular ejection fraction (LVEF) ≤ 40%
- Diabetes mellitus or hypertension requiring pharmacological treatment
Studienplan
Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Verhütung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: 2
|
Oral tablets, 5.0 mg or 2.5 mg, twice daily
Andere Namen:
|
|
Aktiver Komparator: 1
|
Oral tablets, 2.0 mg, adjusted to an INR of 2.5 (range 2.0 to 3.0)
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Number of Participants With First Event of Ischemic/Unspecified Stroke, Hemorrhagic Stroke, or Systemic Embolism (SE) During the Intended Treatment Period
Zeitfenster: Time to first event in "Intended Treatment Period": started on day of randomization, ended at efficacy cut-off date (date target number of primary efficacy events [448] was expected to have occurred; set to 30-Jan-2011, prior to unblinding).
|
All suspected efficacy events were adjudicated by the Central Events Committee (CEC).
Diagnosis of stroke=the nontraumatic focal neurological deficit lasting at least 24 hours, and includes ischemic stroke, hemorrhagic stroke, ischemic stroke with hemorrhagic conversion, stroke of uncertain type, and retinal ischemic event (embolism, infarction).
Diagnosis of SE=clinical history consistent with an acute loss of blood flow to a peripheral artery (or arteries), supported by evidence of embolism from surgical specimens, autopsy, angiography, vascular imaging, or other objective testing.
|
Time to first event in "Intended Treatment Period": started on day of randomization, ended at efficacy cut-off date (date target number of primary efficacy events [448] was expected to have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Rate of Adjudicated Stroke or Systemic Embolism (SE) During the Intended Treatment Period
Zeitfenster: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
Rate=Number of adjudicated stroke or SE events per 100 patient years.
Diagnosis of stroke=the nontraumatic focal neurological deficit lasting at least 24 hours, and includes ischemic stroke, hemorrhagic stroke, ischemic stroke with hemorrhagic conversion, stroke of uncertain type, and retinal ischemic event (embolism, infarction).
Diagnosis of SE=clinical history consistent with an acute loss of blood flow to a peripheral artery (or arteries), supported by evidence of embolism from surgical specimens, autopsy, angiography, vascular imaging, or other objective testing.
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Number of Participants With Event of Major (International Society on Thrombosis and Hemostasis [ISTH]) Bleeding During Treatment Period
Zeitfenster: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
ISTH Bleeding Criteria: Major bleeding=a bleeding event that was: clinically overt bleeding accompanied by a decrease in hemoglobin (Hgb) of 2 g/dL or more, and/or a transfusion of 2 or more units of packed red blood cells; bleeding that occurred in at least 1 of the following critical sites: intracranial, intraspinal, intraocular (within the corpus of the eye; a conjunctival bleed is not an intraocular bleed), pericardial, intra-articular, intramuscular with compartment syndrome, and retroperitoneal; bleeding that was fatal.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of Adjudicated Major (ISTH) Bleed Events During Treatment Period
Zeitfenster: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of adjudicated major (ISTH) bleed events per 100 patient years.
ISTH Bleeding Criteria: Major bleeding=a bleeding event that was: clinically overt bleeding accompanied by a decrease in hemoglobin (Hgb) of 2 g/dL or more and/or a transfusion of 2 or more units of packed red blood cells; bleeding that occurred in at least 1 of the following sites: intracranial, intraspinal, intraocular (within the corpus of the eye; a conjunctival bleed is not an intraocular bleed), pericardial, intra-articular, intramuscular with compartment syndrome, and retroperitoneal; bleeding that was fatal.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Number of Participants With Events of All-Cause Death During the Intended Treatment Period
Zeitfenster: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
Death was defined as all-cause mortality.
All unobserved deaths were assumed to be cardiovascular in nature unless a non-cardiovascular cause could be clearly provided.
Cardiovascular=deaths due to ischemic and hemorrhagic stroke, SE, myocardial infarction (MI), sudden death, heart failure, other cardiovascular, and unobserved deaths.
Non-cardiovascular=all deaths due to a clearly documented non-cardiovascular cause (further classified into the categories: bleeding, study drug toxicity other than bleeding, malignancy, infection, trauma, and pulmonary causes of death).
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Rate of Adjudicated All-Cause Death During the Intended Treatment Period
Zeitfenster: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
All unobserved deaths were assumed to be cardiovascular in nature unless a non-cardiovascular cause could be clearly provided.
Cardiovascular=deaths due to ischemic and hemorrhagic stroke, SE, MI, sudden death, heart failure, other cardiovascular, and unobserved deaths.
Non-cardiovascular=all deaths due to a clearly documented non-cardiovascular cause (further classified into the categories: bleeding, study drug toxicity other than bleeding, malignancy, infection, trauma, and pulmonary causes of death).
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Rate of Ischemic or Unspecified Stroke, Hemorrhagic Stroke, Systemic Embolism (SE), and Myocardial Infarction (MI) (as Individual Endpoints) During the Intended Treatment Period
Zeitfenster: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
Diagnosis for an acute or evolving MI=elevation of creatine kinase-MB isoenzyme (CK-MB) or Troponin T or I ≥ 2 × the upper limit of normal (ULN), or if no CK-MB or troponin values are available, a total CK ≥ 2×ULN, or new, significant (≥0.04 s) Q waves in ≥2 contiguous leads.
For descriptions of Stroke and SE, see Outcome Measure 1.
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Rate of Ischemic or Unspecified Stroke, Hemorrhagic Stroke, Systemic Embolism (SE), Myocardial Infarction (MI) and All-Cause Death (ACD) (as Composite Endpoints) During the Intended Treatment Period
Zeitfenster: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
Diagnosis for an acute or evolving MI=elevation of CK-MB or Troponin T or I ≥ 2 × the ULN, or if no CK-MB or troponin values are available, a total CK ≥ 2×ULN, or new, significant (≥0.04 s) Q waves in ≥2 contiguous leads.
For descriptions of Stroke and SE, see Outcome Measure 1.
For description of ACD, see Outcome Measure 5.
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Number of Warfarin/Vitamin K Antagonist (VKA) Naive Participants With Composite Stroke / Systemic Embolism (SE) / Major Bleeding During the Intended Treatment Period
Zeitfenster: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
For descriptions of Stroke and SE, see Outcome Measure 1.
For description of Major bleeding, see Outcome Measure 3.
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Rate of Composite Stroke / Systemic Embolism / Major Bleeding in Warfarin/Vitamin K Antagonist (VKA) Naive Participants During the Intended Treatment Period
Zeitfenster: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
|
Number of Participants With Events of Major or Clinically Relevant Nonmajor (CRNM) Bleed During Treatment Period
Zeitfenster: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Major bleeding=bleeding that is clinically overt and that either resulted in a decrease in hemoglobin of 2 g/dL or more over a 24-hour period, led to a transfusion of 2 or more units of packed red blood cells, occurred in a critical site, or led to death.
CRNM bleeding=bleeding that is clinically overt, that satisfies none of the additional criteria required for the event to be adjudicated as a major bleeding event, that led to either hospital admission for bleeding, physician-guided medical or surgical treatment for bleeding, or a change in antithrombotic therapy.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of Events of Major or Clinically Relevant Non-Major (CRNM) Bleed During Treatment Period
Zeitfenster: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of major or CRNM bleed events per 100 patient years.
Major=clinically overt and either 1) resulted in a decrease in hemoglobin of 2 g/dL or more, or 2) led to a transfusion of 2 or more units of packed red blood cells, or 3) occurred in a critical site, or 4) led to death.
CRNM bleeding=clinically overt, but satisfied no additional criteria required to be adjudicated as a major bleeding event, and led to either 1) hospital admission for bleeding or 2) physician guided medical or surgical treatment for bleeding or 3) a change in antithrombotic therapy.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Number of Participants With All Bleeding Events During Treatment Period
Zeitfenster: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
All bleeding events include major bleeding, CRNM bleeding (see Outcome Measure 12 Description for definitions), plus events of minor bleeding and fatal bleeding.
Minor bleeding: All acute clinically overt bleeding events not meeting the criteria for either major bleeding or clinically relevant non-major bleeding will be classified as minor bleeding.
Fatal bleeding is defined as a bleeding event that the Clinical Events Committee determines is the primary cause of death or contributes directly to death.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of All Bleeding Events During Treatment Period
Zeitfenster: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of all bleeding events per 100 patient years.
"All bleeding events" include major bleeding, CRNM bleeding (see Outcome Measure 12 Description for definitions), plus events of minor bleeding and fatal bleeding.
Minor bleeding: All acute clinically overt bleeding events not meeting the criteria for either major bleeding or clinically relevant non-major bleeding will be classified as minor bleeding.
Fatal bleeding is defined as a bleeding event that the Clinical Events Committee determines is the primary cause of death or contributes directly to death.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Number of Participants With Adverse Events (AEs), Bleeding AEs, Serious Adverse Events (SAEs), Discontinuations Due to AEs, or Deaths During the Treatment Period
Zeitfenster: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
AE: all SAEs or AEs with onset from first dose through 2 days (AEs) or 30 days (SAEs) after the last dose of blinded study drug (BSD).
SAE: all SAEs with onset from first dose through 30 days after the last dose of BSD.
Bleeding AE: all serious or non-serious bleeding-related AEs with onset from first dose through 2 days after the last dose of BSD.
Discontinuations due to AE: all SAEs or AEs with onset from first dose of BSD and with action taken=drug discontinued.
Deaths: all deaths occurring from first dose through 30 days after the last dose of BSD.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of Adjudicated Bleeding Endpoints Per Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) During the Treatment Period
Zeitfenster: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of adjudicated GUSTO bleeding events per 100 patient years.
GUSTO Bleeding Criteria: GUSTO severe (or life-threatening) bleeding: either intracranial hemorrhage or bleeding that causes hemodynamic compromise and requires intervention.
GUSTO moderate bleeding: bleeding that requires blood transfusion but does not result in hemodynamic compromise.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of Adjudicated Bleeding Endpoints Per Thrombolysis in Myocardial Infarction (TIMI) During the Treatment Period
Zeitfenster: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of adjudicated TIMI bleeding events per 100 patient years.
TIMI Bleeding Criteria: Major bleeding=Intracranial bleeding and/or clinically overt bleeding associated with ≥5 gm/dL fall in Hgb or 15% fall in hematocrit (Hct) from baseline, accounting for transfusions.
Minor bleeding=Clinically overt bleeding associated with ≥3 gm/dL fall in Hgb or a ≥10% fall in Hct from baseline, accounting for transfusions.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Number of Participants With Net-Clinical Benefit During Treatment Period
Zeitfenster: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Net-Clinical Benefit = Composite of stroke, systemic embolism and ISTH major bleeding.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of Net-Clinical Benefit During Treatment Period
Zeitfenster: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of events of net-clinical benefit per 100 patient years.
Net-Clinical Benefit = Composite of stroke, systemic embolism and ISTH major bleeding
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Mitarbeiter und Ermittler
Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.
Sponsor
Publikationen und hilfreiche Links
Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.
Allgemeine Veröffentlichungen
- Jamieson MJ, Byon W, Dettloff RW, Crawford M, Gargalovic PS, Merali SJ, Onorato J, Quintero AJ, Russ C. Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data. Am J Cardiovasc Drugs. 2022 Nov;22(6):615-631. doi: 10.1007/s40256-022-00524-x. Epub 2022 May 16.
- Pol T, Hijazi Z, Lindback J, Oldgren J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Lopes RD, Yusuf S, Siegbahn A, Wallentin L. Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation. Cardiovasc Res. 2022 Jul 20;118(9):2112-2123. doi: 10.1093/cvr/cvab262.
- Pol T, Hijazi Z, Lindback J, Alexander JH, Bahit MC, De Caterina R, Eikelboom JW, Ezekowitz MD, Gersh BJ, Granger CB, Hylek EM, Lopes R, Siegbahn A, Wallentin L. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas. Open Heart. 2021 Mar;8(1):e001471. doi: 10.1136/openhrt-2020-001471.
- Hijazi Z, Wallentin L, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Lopes RD, Pol T, Yusuf S, Oldgren J, Siegbahn A. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation. J Am Heart Assoc. 2020 Dec 15;9(24):e018984. doi: 10.1161/JAHA.120.018984. Epub 2020 Dec 9.
- Wallentin L, Lindback J, Eriksson N, Hijazi Z, Eikelboom JW, Ezekowitz MD, Granger CB, Lopes RD, Yusuf S, Oldgren J, Siegbahn A. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. Eur Heart J. 2020 Nov 1;41(41):4037-4046. doi: 10.1093/eurheartj/ehaa697.
- Hijazi Z, Oldgren J, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Yusuf S, Granger CB, Siegbahn A, Wallentin L; ARISTOTLE and RE-LY Investigators. A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score. Eur Heart J. 2018 Feb 7;39(6):477-485. doi: 10.1093/eurheartj/ehx584.
- Oldgren J, Hijazi Z, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Wallentin L; RE-LY and ARISTOTLE Investigators. Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation. Circulation. 2016 Nov 29;134(22):1697-1707. doi: 10.1161/CIRCULATIONAHA.116.022802. Epub 2016 Aug 28.
- Hijazi Z, Oldgren J, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Granger CB, Wallentin L; ARISTOTLE and RE-LY Investigators. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. Lancet. 2016 Jun 4;387(10035):2302-2311. doi: 10.1016/S0140-6736(16)00741-8. Epub 2016 Apr 4.
- Hijazi Z, Lindback J, Alexander JH, Hanna M, Held C, Hylek EM, Lopes RD, Oldgren J, Siegbahn A, Stewart RA, White HD, Granger CB, Wallentin L; ARISTOTLE and STABILITY Investigators. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. Eur Heart J. 2016 May 21;37(20):1582-90. doi: 10.1093/eurheartj/ehw054. Epub 2016 Feb 25.
- Hijazi Z, Granger CB, Hohnloser SH, Westerbergh J, Lindback J, Alexander JH, Keltai M, Parkhomenko A, Lopez-Sendon JL, Lopes RD, Siegbahn A, Wallentin L. Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation. J Am Heart Assoc. 2020 Sep 15;9(18):e017155. doi: 10.1161/JAHA.120.017155. Epub 2020 Aug 31.
- Zeitouni M, Giczewska A, Alexander JH. Reply: Specifics of Dose Modification in ARISTOTLE. J Am Coll Cardiol. 2020 Jul 7;76(1):128-129. doi: 10.1016/j.jacc.2020.05.013. No abstract available.
- Rosjo H, Hijazi Z, Omland T, Westerbergh J, Lyngbakken MN, Alexander JH, Gersh BJ, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Wallentin L. Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial. J Intern Med. 2020 Aug;288(2):248-259. doi: 10.1111/joim.13072. Epub 2020 May 18.
- Zeitouni M, Giczewska A, Lopes RD, Wojdyla DM, Christersson C, Siegbahn A, De Caterina R, Steg PG, Granger CB, Wallentin L, Alexander JH; ARISTOTLE Investigators. Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial. J Am Coll Cardiol. 2020 Mar 17;75(10):1145-1155. doi: 10.1016/j.jacc.2019.12.060.
- Stanifer JW, Pokorney SD, Chertow GM, Hohnloser SH, Wojdyla DM, Garonzik S, Byon W, Hijazi Z, Lopes RD, Alexander JH, Wallentin L, Granger CB. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease. Circulation. 2020 Apr 28;141(17):1384-1392. doi: 10.1161/CIRCULATIONAHA.119.044059. Epub 2020 Mar 12.
- Garcia DA, Fisher DA, Mulder H, Wruck L, De Caterina R, Halvorsen S, Granger CB, Held C, Wallentin L, Alexander JH, Lopes RD. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2020 Mar;221:1-8. doi: 10.1016/j.ahj.2019.10.013. Epub 2019 Oct 31.
- Dalgaard F, Mulder H, Wojdyla DM, Lopes RD, Held C, Alexander JH, De Caterina R, Washam JB, Hylek EM, Garcia DA, Gersh BJ, Wallentin L, Granger CB, Al-Khatib SM. Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial. Circulation. 2020 Jan 7;141(1):10-20. doi: 10.1161/CIRCULATIONAHA.119.041296. Epub 2019 Nov 21.
- Goldstein SA, Green J, Huber K, Wojdyla DM, Lopes RD, Alexander JH, Vinereanu D, Wallentin L, Granger CB, Al-Khatib SM. Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial). Am J Cardiol. 2019 Nov 1;124(9):1406-1412. doi: 10.1016/j.amjcard.2019.07.046. Epub 2019 Aug 7.
- Guimaraes PO, Pokorney SD, Lopes RD, Wojdyla DM, Gersh BJ, Giczewska A, Carnicelli A, Lewis BS, Hanna M, Wallentin L, Vinereanu D, Alexander JH, Granger CB. Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial. Clin Cardiol. 2019 May;42(5):568-571. doi: 10.1002/clc.23178. Epub 2019 Apr 9.
- Washam JB, Hohnloser SH, Lopes RD, Wojdyla DM, Vinereanu D, Alexander JH, Gersh BJ, Hanna M, Horowitz J, Hylek EM, Xavier D, Verheugt FWA, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators. Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial. J Thromb Thrombolysis. 2019 Apr;47(3):345-352. doi: 10.1007/s11239-019-01823-y.
- Hohnloser SH, Fudim M, Alexander JH, Wojdyla DM, Ezekowitz JA, Hanna M, Atar D, Hijazi Z, Bahit MC, Al-Khatib SM, Lopez-Sendon JL, Wallentin L, Granger CB, Lopes RD. Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight. Circulation. 2019 May 14;139(20):2292-2300. doi: 10.1161/CIRCULATIONAHA.118.037955.
- Alexander KP, Brouwer MA, Mulder H, Vinereanu D, Lopes RD, Proietti M, Al-Khatib SM, Hijazi Z, Halvorsen S, Hylek EM, Verheugt FWA, Alexander JH, Wallentin L, Granger CB; ARISTOTLE Investigators. Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial. Am Heart J. 2019 Feb;208:123-131. doi: 10.1016/j.ahj.2018.09.017. Epub 2018 Nov 22.
- Sandhu RK, Ezekowitz JA, Hijazi Z, Westerbergh J, Aulin J, Alexander JH, Granger CB, Halvorsen S, Hanna MS, Lopes RD, Siegbahn A, Wallentin L. Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial. Open Heart. 2018 Nov 1;5(2):e000908. doi: 10.1136/openhrt-2018-000908. eCollection 2018.
- Christersson C, Wallentin L, Andersson U, Alexander JH, Alings M, De Caterina R, Gersh BJ, Granger CB, Halvorsen S, Hanna M, Huber K, Hylek EM, Lopes RD, Oh BH, Siegbahn A. Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation. Heart. 2019 Feb;105(3):235-242. doi: 10.1136/heartjnl-2018-313351. Epub 2018 Sep 12.
- Horowitz JD, De Caterina R, Heresztyn T, Alexander JH, Andersson U, Lopes RD, Steg PG, Hylek EM, Mohan P, Hanna M, Jansky P, Granger CB, Wallentin L; ARISTOTLE Investigators. Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy. J Am Coll Cardiol. 2018 Aug 14;72(7):721-733. doi: 10.1016/j.jacc.2018.05.058.
- Sharma A, Hijazi Z, Andersson U, Al-Khatib SM, Lopes RD, Alexander JH, Held C, Hylek EM, Leonardi S, Hanna M, Ezekowitz JA, Siegbahn A, Granger CB, Wallentin L. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation. Circulation. 2018 Oct 16;138(16):1666-1676. doi: 10.1161/CIRCULATIONAHA.118.034125.
- Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. Am Heart J. 2018 Mar;197:133-141. doi: 10.1016/j.ahj.2017.11.005. Epub 2017 Nov 10.
- Pol T, Held C, Westerbergh J, Lindback J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z. Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial. J Am Heart Assoc. 2018 Feb 1;7(3):e007444. doi: 10.1161/JAHA.117.007444.
- Goto S, Merrill P, Wallentin L, Wojdyla DM, Hanna M, Avezum A, Easton JD, Harjola VP, Huber K, Lewis BS, Parkhomenko A, Zhu J, Granger CB, Lopes RD, Alexander JH. Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE. Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):75-81. doi: 10.1093/ehjcvp/pvy002.
- Vinereanu D, Wang A, Mulder H, Lopes RD, Jansky P, Lewis BS, Gersh BJ, Avezum A, Hanna M, Held C, Wallentin L, Granger CB, Alexander JH. Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease. Heart. 2018 Aug;104(15):1292-1299. doi: 10.1136/heartjnl-2017-312272. Epub 2018 Jan 19.
- Rao MP, Vinereanu D, Wojdyla DM, Alexander JH, Atar D, Hylek EM, Hanna M, Wallentin L, Lopes RD, Gersh BJ, Granger CB; Apixaban for Reduction in Stroke Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators. Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial. Am J Med. 2018 Mar;131(3):269-275.e2. doi: 10.1016/j.amjmed.2017.10.036. Epub 2017 Nov 6.
- Vinereanu D, Lopes RD, Mulder H, Gersh BJ, Hanna M, de Barros E Silva PGM, Atar D, Wallentin L, Granger CB, Alexander JH; ARISTOTLE Investigators. Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin. Stroke. 2017 Dec;48(12):3266-3273. doi: 10.1161/STROKEAHA.117.017574. Epub 2017 Oct 31.
- Hijazi Z, Lindahl B, Oldgren J, Andersson U, Lindback J, Granger CB, Alexander JH, Gersh BJ, Hanna M, Harjola VP, Hylek EM, Lopes RD, Siegbahn A, Wallentin L. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time. J Am Heart Assoc. 2017 Jun 23;6(6):e004851. doi: 10.1161/JAHA.116.004851.
- Lopes RD, Guimaraes PO, Kolls BJ, Wojdyla DM, Bushnell CD, Hanna M, Easton JD, Thomas L, Wallentin L, Al-Khatib SM, Held C, Gabriel Melo de Barros E Silva P, Alexander JH, Granger CB, Diener HC. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy. Blood. 2017 Jun 1;129(22):2980-2987. doi: 10.1182/blood-2016-08-731638. Epub 2017 Mar 29.
- Cowper PA, Sheng S, Lopes RD, Anstrom KJ, Stafford JA, Davidson-Ray L, Al-Khatib SM, Ansell J, Dorian P, Husted S, McMurray JJV, Steg PG, Alexander JH, Wallentin L, Granger CB, Mark DB. Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial. JAMA Cardiol. 2017 May 1;2(5):525-534. doi: 10.1001/jamacardio.2017.0065.
- Hu PT, Lopes RD, Stevens SR, Wallentin L, Thomas L, Alexander JH, Hanna M, Lewis BS, Verheugt FW, Granger CB, Jones WS. Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial. J Am Heart Assoc. 2017 Jan 17;6(1):e004699. doi: 10.1161/JAHA.116.004699.
- Bahit MC, Lopes RD, Wojdyla DM, Held C, Hanna M, Vinereanu D, Hylek EM, Verheugt F, Goto S, Alexander JH, Wallentin L, Granger CB. Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation. Heart. 2017 Apr;103(8):623-628. doi: 10.1136/heartjnl-2016-309901. Epub 2016 Oct 24.
- Alexander JH, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz JA, Halvorsen S, Hanna M, Commerford P, Ruzyllo W, Huber K, Al-Khatib SM, Granger CB, Wallentin L; Apixaban for Reduction of Stroke and Other Thromboembolic Complications in Atrial Fibrillation (ARISTOTLE) Investigators. Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2016 Sep 1;1(6):673-81. doi: 10.1001/jamacardio.2016.1829.
- Hijazi Z, Hohnloser SH, Andersson U, Alexander JH, Hanna M, Keltai M, Parkhomenko A, Lopez-Sendon JL, Lopes RD, Siegbahn A, Granger CB, Wallentin L. Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial. JAMA Cardiol. 2016 Jul 1;1(4):451-60. doi: 10.1001/jamacardio.2016.1170.
- Jaspers Focks J, Brouwer MA, Wojdyla DM, Thomas L, Lopes RD, Washam JB, Lanas F, Xavier D, Husted S, Wallentin L, Alexander JH, Granger CB, Verheugt FW. Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial. BMJ. 2016 Jun 15;353:i2868. doi: 10.1136/bmj.i2868.
- Hijazi Z, Aulin J, Andersson U, Alexander JH, Gersh B, Granger CB, Hanna M, Horowitz J, Hylek EM, Lopes RD, Siegbahn A, Wallentin L; ARISTOTLE Investigators. Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation. Heart. 2016 Apr;102(7):508-17. doi: 10.1136/heartjnl-2015-308887. Epub 2016 Feb 2.
- Rao MP, Halvorsen S, Wojdyla D, Thomas L, Alexander JH, Hylek EM, Hanna M, Bahit MC, Lopes RD, De Caterina R, Erol C, Goto S, Lanas F, Lewis BS, Husted S, Gersh BJ, Wallentin L, Granger CB; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Steering Committee and Investigators. Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. J Am Heart Assoc. 2015 Dec 1;4(12):e002015. doi: 10.1161/JAHA.115.002015. Erratum In: J Am Heart Assoc. 2021 Feb 16;10(4):e014653.
- Vinereanu D, Stevens SR, Alexander JH, Al-Khatib SM, Avezum A, Bahit MC, Granger CB, Lopes RD, Halvorsen S, Hanna M, Husted S, Hylek EM, Margulescu AD, Wallentin L, Atar D. Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial. Eur Heart J. 2015 Dec 7;36(46):3268-75. doi: 10.1093/eurheartj/ehv447. Epub 2015 Sep 14.
- Avezum A, Lopes RD, Schulte PJ, Lanas F, Gersh BJ, Hanna M, Pais P, Erol C, Diaz R, Bahit MC, Bartunek J, De Caterina R, Goto S, Ruzyllo W, Zhu J, Granger CB, Alexander JH. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. Circulation. 2015 Aug 25;132(8):624-32. doi: 10.1161/CIRCULATIONAHA.114.014807. Epub 2015 Jun 23.
- Held C, Hylek EM, Alexander JH, Hanna M, Lopes RD, Wojdyla DM, Thomas L, Al-Khalidi H, Alings M, Xavier D, Ansell J, Goto S, Ruzyllo W, Rosenqvist M, Verheugt FW, Zhu J, Granger CB, Wallentin L. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial. Eur Heart J. 2015 May 21;36(20):1264-72. doi: 10.1093/eurheartj/ehu463. Epub 2014 Dec 12.
- Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L. Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. Clin Chem. 2015 Feb;61(2):368-78. doi: 10.1373/clinchem.2014.226936. Epub 2014 Dec 1.
- Garcia D, Alexander JH, Wallentin L, Wojdyla DM, Thomas L, Hanna M, Al-Khatib SM, Dorian P, Ansell J, Commerford P, Flaker G, Lanas F, Vinereanu D, Xavier D, Hylek EM, Held C, Verheugt FW, Granger CB, Lopes RD. Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. Blood. 2014 Dec 11;124(25):3692-8. doi: 10.1182/blood-2014-08-595496. Epub 2014 Oct 15.
- Wallentin L, Hijazi Z, Andersson U, Alexander JH, De Caterina R, Hanna M, Horowitz JD, Hylek EM, Lopes RD, Asberg S, Granger CB, Siegbahn A; ARISTOTLE Investigators. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation. 2014 Nov 18;130(21):1847-58. doi: 10.1161/CIRCULATIONAHA.114.011204. Epub 2014 Oct 7.
- Hijazi Z, Siegbahn A, Andersson U, Granger CB, Alexander JH, Atar D, Gersh BJ, Mohan P, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L; ARISTOTLE Investigators. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation. 2014 Feb 11;129(6):625-34. doi: 10.1161/CIRCULATIONAHA.113.006286. Epub 2013 Nov 13.
- Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B, Zhu J, Mohan P, Garcia D, Bartunek J, Vinereanu D, Husted S, Harjola VP, Rosenqvist M, Alexander JH, Granger CB; ARISTOTLE Committees and Investigators. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation). J Am Coll Cardiol. 2014 Mar 25;63(11):1082-7. doi: 10.1016/j.jacc.2013.09.062. Epub 2013 Nov 6.
- Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJ, Granger CB; ARISTOTLE Investigators. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. J Am Coll Cardiol. 2014 Jan 7-14;63(1):52-61. doi: 10.1016/j.jacc.2013.07.093. Epub 2013 Sep 19.
- Alexander JH, Levy E, Lawrence J, Hanna M, Waclawski AP, Wang J, Califf RM, Wallentin L, Granger CB. Documentation of study medication dispensing in a prospective large randomized clinical trial: experiences from the ARISTOTLE Trial. Am Heart J. 2013 Sep;166(3):559-65. doi: 10.1016/j.ahj.2013.05.025. Epub 2013 Aug 15.
- Garcia DA, Wallentin L, Lopes RD, Thomas L, Alexander JH, Hylek EM, Ansell J, Hanna M, Lanas F, Flaker G, Commerford P, Xavier D, Vinereanu D, Yang H, Granger CB. Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. Am Heart J. 2013 Sep;166(3):549-58. doi: 10.1016/j.ahj.2013.05.016. Epub 2013 Jul 25.
- Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, Hylek EM, Al-Khatib SM, Alexander JH, Alings M, Amerena J, Ansell J, Aylward P, Bartunek J, Commerford P, De Caterina R, Erol C, Harjola VP, Held C, Horowitz JD, Huber K, Husted S, Keltai M, Lanas F, Lisheng L, McMurray JJ, Oh BH, Rosenqvist M, Ruzyllo W, Steg PG, Vinereanu D, Xavier D, Granger CB; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation. 2013 Jun 4;127(22):2166-76. doi: 10.1161/CIRCULATIONAHA.112.142158. Epub 2013 May 2.
- McMurray JJ, Ezekowitz JA, Lewis BS, Gersh BJ, van Diepen S, Amerena J, Bartunek J, Commerford P, Oh BH, Harjola VP, Al-Khatib SM, Hanna M, Alexander JH, Lopes RD, Wojdyla DM, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators. Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial. Circ Heart Fail. 2013 May;6(3):451-60. doi: 10.1161/CIRCHEARTFAILURE.112.000143. Epub 2013 Apr 10.
- Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Christersson C, Ezekowitz J, Gersh BJ, Hanna M, Hohnloser S, Horowitz J, Huber K, Hylek EM, Lopes RD, McMurray JJ, Granger CB. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol. 2013 Jun 4;61(22):2274-84. doi: 10.1016/j.jacc.2012.11.082. Epub 2013 Apr 3.
- Lopes RD, Al-Khatib SM, Wallentin L, Yang H, Ansell J, Bahit MC, De Caterina R, Dorian P, Easton JD, Erol C, Ezekowitz JA, Gersh BJ, Granger CB, Hohnloser SH, Horowitz J, Hylek EM, McMurray JJ, Mohan P, Vinereanu D, Alexander JH. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. Lancet. 2012 Nov 17;380(9855):1749-58. doi: 10.1016/S0140-6736(12)60986-6. Epub 2012 Oct 2. Erratum In: Lancet. 2013 Jan 19;381(9862):204.
- Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum In: Lancet Neurol. 2012 Dec;11(12):1021.
- Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.
Nützliche Links
Studienaufzeichnungsdaten
Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.
Haupttermine studieren
Studienbeginn (Tatsächlich)
31. Dezember 2006
Primärer Abschluss (Tatsächlich)
25. Mai 2011
Studienabschluss (Tatsächlich)
25. Mai 2011
Studienanmeldedaten
Zuerst eingereicht
18. Dezember 2006
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
18. Dezember 2006
Zuerst gepostet (Schätzen)
19. Dezember 2006
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
3. Juli 2018
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
5. Juni 2018
Zuletzt verifiziert
1. Mai 2018
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
- Pathologische Prozesse
- Herzkrankheiten
- Herz-Kreislauf-Erkrankungen
- Arrhythmien, Herz
- Vorhofflimmern
- Vorhofflattern
- Molekulare Mechanismen der pharmakologischen Wirkung
- Enzym-Inhibitoren
- Protease-Inhibitoren
- Faktor Xa-Hemmer
- Antithrombine
- Serinproteinase-Inhibitoren
- Antikoagulanzien
- Apixaban
- Warfarin
Andere Studien-ID-Nummern
- CV185-030
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Vorhofflimmern
-
Institut universitaire de cardiologie et de pneumologie...RekrutierungIdiopathisches Kammerflimmern | Kurzgekoppelte ventrikuläre FibrillationNiederlande, Kanada
-
IRCCS Policlinico S. MatteoUniversity of Pavia; Azienda Regionale Emergenza Urgenza (AREU)RekrutierungAußerklinischer Herzstillstand | Ventrikuläre Fibrillation anhaltendItalien
-
Wake Forest University Health SciencesRekrutierungVorhofflimmern | Tachykardie atrial | Vorhofflattern mit schneller ventrikulärer ReaktionVereinigte Staaten
-
Biotronik SE & Co. KGAbgeschlossenVorhofflimmern | Bradykardie | Synkope | Kryptogener Schlaganfall | Tachykardie atrialItalien
-
Edgar JaeggiLabatt Family Heart CentreAbgeschlossenVorhofflattern | Tachykardie, supraventrikulär | Tachykardie, AV-Knoten-Wiedereintritt | Tachykardie atrial | Tachykardie, reziprok | Tachykardie, paroxysmal | Fetaler Hydrops | Tachykardie, atriale EktopieVereinigte Staaten, Vereinigtes Königreich, Kanada, Hongkong, Niederlande, Tschechien, Schweden, Australien, Brasilien, Finnland, Frankreich, Russische Föderation, Spanien, Schweiz
Klinische Studien zur warfarin
-
Academia Sinica, TaiwanChina Medical University Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical...AbgeschlossenStreicheln | Venöse Thrombose | Vorhofflimmern | VorhofflatternTaiwan
-
Asan Medical CenterNoch keine RekrutierungFortgeschrittene Herzinsuffizienz | Blutungskomplikationen | Antikoagulationsbehandlung | Linksherzunterstützungsgeräte | Thrombotische KomplikationenKorea, Republik von
-
National University Hospital, SingaporeUnbekanntIndikationen für die Warfarin-TherapieSingapur, Malaysia
-
University of KarachiAdvanced Education & Research Center; Karachi Institute of Heart DiseasesRekrutierungAneurysma des linken Vorhofohrs | MitralstenosePakistan
-
China National Center for Cardiovascular DiseasesAbgeschlossenVorhofflimmern | HerzklappenerkrankungenChina
-
Xi ZhangSun Yat-sen UniversityUnbekanntHerzklappenerkrankungen | Überdosierung einer AntikoagulationsbehandlungChina
-
Chinese PLA General HospitalUnbekanntVorhofflimmern | Tiefe Venenthrombose | Lungenembolie | HerzklappenerkrankungChina
-
Ankara UniversityUnbekanntVorhofflimmern | Periphere Gefäßerkrankung | Tiefe Venenthrombose | Lungenembolie | Herzthrombus | Herzklappenersatz (mechanisch oder biologisch mit AF) | Kardiomyopathie (ischämisch oder dilatiert)Truthahn
-
Aalborg University HospitalAbgeschlossen
-
Iverson Genetic Diagnostics, Inc.SuspendiertVorhofflimmern | Lungenembolie | TVT | Prothetischer Ersatz der Mitralklappe | Antikoagulationstherapie | Gelenkchirurgie mehrfachVereinigte Staaten